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An integrated computational-experimental approach for the in situ 
estimation of valve interstitial cell biomechanical state 
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Mechanical forces are known to regulate aortic valve interstitial cell (AVIC) 
functional state by modulating their biosynthetic activity, translating to differences in 
tissue composition and structure and, potentially, leading to aortic valve (AV) 
dysfunction. While advances have been made toward the understanding of AVIC 
behavior ex-situ, the AVIC biomechanical state in its native extracellular matrix (ECM) 
remains largely unknown. Consequently, changes in AVIC behaviors, such as stiffness 
and contractility, resulting from pathological cues in-situ remain unidentified. We 
hypothesize that improved descriptions of AVIC biomechanical state in-situ, obtained 
using an inverse modeling approach, will provide deeper insight into AVIC interactions 
with the surrounding ECM, revealing important changes resulting from pathological 
state, and possibly informing pharmaceutical therapies. To achieve this, a novel 
integrated numerical-experimental framework to estimate AVIC mechanobiological state 
in-situ was developed. Flexural deformation of intact AV leaflets was used to quantify 
the effects of AVIC stiffness and contraction at the tissue level. In addition to being a 
relevant deformation mode of the cardiac cycle, flexure is highly sensitive to layer-
specific changes in AVIC biomechanics. As a first step, a tissue-level bilayer model that 
accurately captures the bidirectional flexural response of AV intact layers in a passive 
 vii 
state was developed. Next, tissue micromorphology was incorporated in a macro-micro 
scale framework to simulate layer-specific AVIC-ECM interactions. The macro-micro 
AV model enables the estimation of changes in effective AVIC stiffness and contraction 
in-situ that are otherwise grossly inaccessible through experimental approaches alone. 
Finally, microindentation studies examining AVIC activation were run in parallel with in-
situ studies to emphasize the necessity of an in-situ approach, and the advantage it affords 
over existing ex-situ methodology. In conclusion, the developed numerical-experimental 
methodology can be used to obtain AVIC properties in-situ. Most importantly, it can lead 
to further understanding of AVIC-ECM mechanical coupling under various 
pathophysiological conditions and the investigation of possible treatment strategies 
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CHAPTER 1: INTRODUCTION 
Preface 
Heart valves play a critical role in ensuring unidirectional blood flow in 
mammalian hearts throughout the cardiac cycle. They are engineered to withstand the 
demanding mechanical environment of the heart and remaining durable through 
continuous extracellular matrix (ECM) remodeling. This introductory chapter introduces 
the link between disease-induced alterations in valve tissue and the subsequent cell 
mechanobiological responses and tissue remodeling. First, an overview of the 
fundamentals of heart valve physiology and the characteristics and functions of valve 
interstitial cells (VIC) is provided. Then current experimental and computational 
approaches that connect VIC mechanobiological response to organ- and tissue-level 
deformations and improve our understanding of the underlying functional physiology of 
heart valves are discussed. A summary is provided of future trends the outlook of heart 
valve mechanobiology, specifically multi-scale modeling approaches. Finally, the 
motivation, rationale and research aims of this dissertation are outlined emphasizing the 
importance of investigating AVIC mechanobiological responses while maintaining native 
valve tissue micromorphology to gain a more accurate representation of clinical AVIC 
behavior. 
HEART VALVE STRUCTURE AND FUNCTION 
Heart valves are complex multi-layered structures that serve to prevent retrograde 
flow in the right and left ventricles by their opening and closing motion caused by 
differential blood pressure on each side. The heart contains four valves, two residing 
within the left heart chamber: mitral valve (MV) and aortic valve (AV) and an additional 
two within the right chambers: tricuspid valve (TV) and pulmonary valve (PV) shown in 
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Fig. 1.1. Differences in morphology divide them into two categories: atrioventricular 
(MV and TV) that assist in unidirectional blood flow between the atria and ventricle as 
the name implies, and semilunar (AV and PV) that direct blood flow from the ventricles 
out of the heart through major arteries.  
When healthy, heart valves are incredibly resilient, opening and closing 
approximately 4 billion times throughout an average life-span [1]. The valves residing on 
the left side of the heart (AV and MV) experience 5-8 fold higher transvalvular pressures 
(TVP) of 80mmHg for the AV and 120mmHg for the MV, compared with the left side 
heart valves that experience 10mmHg (PV) and 25mmHg (TV) [1]. Although they 
function as simple check valves that control the unidirectional flow of blood during the 
cardiac cycle, these complex structures are uniquely adapted to withstand demanding 
mechanical and hemodynamic environments unlike any other found in the body. Each 
heart valve is uniquely engineered by nature to optimize their individual roles in the 
cardiac cycles, enabling them to maximize flow rate while minimizing flow resistance. 
Structure of the AV at multiple length scales 
The structure of the native aortic heart valve spans multiple length scales: organ, 
tissue, cell and molecular. This complex hierarchical structure is what lends to seamless 
heart valve performance under highly dynamic loading conditions. An overview of heart 
valve structure-functional relationships is provided in Fig. 1.2. As this dissertation 
focuses specifically on the structure-functional relationship at the tissue-cell interface in 
the aortic valve, the structure and biomechanics of the other three valves will not be 
discussed in detail. At the organ level the aortic valve is comprised of three cusps named 
after their locations relative to the coronary arteria ostia in the sinuses of Valsalva: the 
left coronary, right coronary, and noncoronary. The leaflets cusps attach to the left 
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ventricle at their basal attachment, forming what is known as the virtual annulus and they 
attach distally to the aortic root at what is termed the aorto-ventricular junction. The 
leaflets components can be described by four parts: the hinge, the belly, the coapting 
surface and the lannula with the noduli of Aranti. The nodule of Arantius is a small 
fibrous area that forms in the center of the cusp, when the closing edge meets the free 
edge of the leaflet at the coapting surface. On either side of the nodule is a thin cresent-
shaped portion called the ‘lannula’, which is thin at its free end and continues to the 
coaptation region where the three leaflets come together during valve closure.  The 
lannulae attach to the aortic wall at the commissure region and form the valvular hinge. 
The main portion of the leaflet is called the belly [2].  
At the tissue level, each AV leaflet is a thin (200-500 micron) heterogeneous 
membrane structure composed of three histologically distinct layers: the fibrosa, 
spongiosa, and ventricularis (Fig. 1.3). Each layer contains varying amounts of collagen, 
glycosaminoglycan (GAG), and elastin [3]. The fibrosa layer, facing the outflow surface, 
consists primarily of a dense network of highly aligned type 1 collagen fibers and 
contributes to about 45% of the valve thickness. The central spongiosa layer, 
approximately 30% of the leaflet thickness is rich in glycosaminoglycans and water [4]. 
The ventricularis layer, the remaining 25% of the leaflet faces the left ventricle inflow 
surface and is composed of elastin and disorganized collagen. Taken collectively, the 
three layers of the AV with their elastin, collagen and glycosaminoglycans constituents 
comprise ECM of the valve. In addition to the biomechanical role the ECM plays in valve 
function, it provides a support structure for the underlying valve cell network. The ECM 
influences cell behavior by providing a source of ligands for cell surface receptors, which 
transfer mechanical strains experienced at the tissue level down to the cells and 
ultimately initiating intracellular signaling pathways [5].  Furthermore, differences in 
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innate mechanical properties of the constituents can influence the underlying function of 
the cells as suggested by a growing body of research demonstrating that the phenotype 
and function of cells, including valve cells, are influenced by the stiffness of the substrate 
to which they are adhered [6]. 
Valve endothelial cells 
Valve endothelial cells (VEC) play an important role in the establishment of valve 
structure during embryonic development and are essential for maintaining the valve’s 
lifelong integrity and function. Endothelial cells line the surfaces of both blood vessels as 
well as heart valve leaflets. These cells are critical in the maintenance of a 
nonthrombogenic surface, nutrient transport, and mechanotransduction [7]. This said, 
VECs have been shown to be morphologically different from aortic ECs [7-9]. In healthy 
valves, VECs form a continuous endothelium and have an important role, which consists 
of regulating vascular tone, inflammation, thrombosis, and remodeling [10]. This 
function however, is different in malfunctioning and diseased valves in which VECs are 
disrupted. Heart valve failure has been traced to endothelial dysfunction and denudation 
[7], giving rise to valve leaflet thickening (sclerosis) and/or calcification and leading to 
an attenuation of responses to molecular and hemodynamic cues [11, 12].  
Many groups have made important insights on endothelial function in different 
mechanical environments using different in vitro experimental set-ups. Endothelial cells 
reorganize their cytoskeletal filaments and focal adhesion complexes to align parallel to 
the direction of unidirectional flow while secreting vasoactive agents, such as nitric oxide 
and prostaglandin [13-15]. Biomechanical stimuli exerted by blood flow, blood pressure, 
and cyclic strain cause endothelial cells to alter their morphology, growth rate, 
metabolism, and gene expression profile to ensure proper morphogenesis but also 
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homeostasis. This is done through the activation of surface glycoproteins, cell adhesion 
molecules, secondary messengers, and phosphorylation of surface receptors [16]. Several 
groups have investigated the disruption of the endothelial cell mechanotransduction and 
its effect on cell mechanobiology through the oscillation of fluid flow direction and 
signal pathway blockade [17-22]. Data from these studies suggested that disruptions in 
these signaling events inhibit focal adhesion reorganization and consequently, cell 
alignment and agent release [7].  
Although a significant amount of information is available on vascular endothelial 
cells, little is known about valve specific endothelial cells or VECs. The work by Nerem 
et al. has been instrumental in understanding VEC morphology, mechanobiology, and 
mechanotransduction. In vitro, VECs grow into cobblestone-like morphology and align 
perpendicular to fluid flow but parallel to the leaflet collagen fibers [23, 24], in contrast 
to vascular endothelial cells, which align parallel to fluid flow. The differing shear stress 
response of valve endothelial stress and vascular endothelial cells is due to observed 
differential molecular profiles and functional responses of these cell populations [25, 26]. 
Recent work by Butcher et al. indicates that unlike vascular endothelial alignment, VEC 
alignment to fluid flow is mediated by the reorganization of focal adhesions within the 
cell and though it is calpain- and Rho-kinase-dependent like the vascular endothelial 
cells, it is independent of phosphatidylinositol 3-kinase (PI3K) [7].  
Pathological changes in vascular endothelial cell-mediated responses have been 
associated with atherosclerosis, thrombosis, stroke, and hypertension [16]. Valvular heart 
disease, a major cause of morbidity in the United States and around the world, is not only 
due to dysfunctional changes in VIC proliferation and ECM organization, but also VEC 
histopathological alterations. Some light has been recently shed on the events that initiate 
VEC dysfunction in diseased valves. Both genetic mutations associated with NOTCH1, 
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Gata5, and endothelial-nitric oxide synthase (eNOS or NOS3) [27, 28], as well as 
atherosclerosis-related environmental risk factors, such as diet [29, 30], smoking, ageing 
[30, 31], hypertension, and diabetes, have been associated with valve pathogenesis [32].  
This said, hemodynamic flow across the endothelium is the major player in the injury and 
subsequent dysfunction of both vascular as well as valvular endothelial cells. It is known 
that in the healthy heart, the left side of the heart is subject to greater stress due to the 
high-pressure difference that exists between the left atrium and the left ventricle. Thus, 
hemodynamic forces have a greater impact on the mitral and aortic valves than on the 
tricuspid and pulmonary valves [33, 34].  Similarly, endothelia on opposing sides of the 
valves are subjected to very different hemodynamics [12, 35, 36], which can be linked to 
the distinctly different patterns of focal calcification on the aortic side of the AV [37-39]. 
Several in vitro studies have highlighted the link between hemodynamics and VEC 
molecular responses and linked it to valvular heart disease. Recent work by Simmons et 
al. and Butcher et al. indicates that VECs activate fibro-calcific responses to increases in 
hemodynamic forces (i.e., fluid shear stress, cyclic strain, and hydrostatic pressure) [40] 
and does so in a side-specific manner (i.e., VECs from the aortic side are protected from 
inflammatory processes compared to VECs isolated from the ventricular surface) [41].  
Valve interstitial cells 
Under the single layer of VECs that line both surfaces of the leaflet, reside a 
heterogeneous population of cells called VICs. VICs native to each of the four valves are 
named accordingly as MVICs (mitral), AVICs (aortic), PVICs (pulmonary) and TVICs 
(triscupid). VICs are evenly dispersed throughout the layers of the valve. Within the 
proximal third of the leaflets, in which innervation occurs, a feedback mechanism 
between VECs and VICs exists, wherein the nerves transmit information on released 
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substances from VECs [42]. Release of cytokines has been shown to cause changes in 
interstitial cell structure and function [43, 44] and it was speculated that there exists some 
physical VEC/VIC communication. This said, no direct junctions have been observed to 
date between the two cell populations [45]. The role of VICs is to maintain the 
extracellular matrix (ECM) of the valve through the constant turnover of constituents 
through the synthesis of new proteins and the enzymatic digestion of old or damaged 
proteins [46]. The phenotype of VICs is highly plastic and reversible, indicating the state 
of the tissue from a developing, remodeling, diseased or normal valve. When healthy, 
VICs have heterogeneous characteristics that resemble most closely those of fibroblasts 
and smooth muscle cells and are considered to be in a quiescent state [46-49]. During the 
onset of injury or disease, the VICs are activated and become highly contractile, showing 
characteristics of myofibroblasts. The myofibroblast-like VICs have been observed both 
in-situ and using cultured porcine valves through electron microscopy and 
immunocytochemistry. They are characterized by prominent stress fibers expressing 
alpha smooth muscle actin (α-SMA). The contractile phenotype initiates an increase in 
remodeling of the ECM, relative to quiescent AVICs. AVICs are physically connected to 
the surrounding ECM through integrins, facilitating adhesion and mechanotransduction. 
[46]. Integrins are composed of α and β subunits, giving rise to at least 24 identified 
integrins with distinct ligand specificities. Integrins make transmembrane connections to 
the cytoskeleton via proteins such as talin and α-actinin at focal adhesion complexes. The 
expression of integrins in aortic valves has been investigated by Latif et al. and reported 
the highest expression for α2β1, and α3β1 complexes [50]. Furthermore, Stephens et al. 
provided evidence that actin-mediated VIC force generation coupled to collagen via α2β1 
integrins is necessary for force generation in the mitral leaflet [51]. These results may 
 8 
suggest that AVIC-collagen coupling, mediated by α2β1 integrins, is also necessary for 
KCl induced force generation in the aortic leaflet. 
Extensive evidence exists in literature emphasizing the role of the 
microenvironment on cell behavior. The AVICs are no exception and the surrounding 
ECM defines the AVIC micromechanical environment by providing resistance to cell-
generated traction forces. Through integrin-mediated adhesion and actinmyosin 
contraction, AVICs are able to sense local elasticity of their ECM by physically pulling 
on the substrate. These exerted traction forces are transmitted to the substrate at focal 
adhesion sites. AVICs then respond to the detected elasticity by altering integrin 
expression, focal adhesions, and cytoskeletal organization in order to establish force 
balance between substrate resistance and AVIC generated traction force. Cytoskeletal 
organization and tension in turn regulate intracellular signaling pathways. Therefore, 
changes in the AVIC microenvironment directly impact valve biomechanical function in 
this manner, leading to clinical manifestations such as calcific aortic valve disease, to be 
discussed in a proceeding section. 
Biomechanical function 
At the tissue level, mechanics of the heart valves can be summarized in three 
physical loading modes: tension, shear, and flexure. In a cyclical manner the valve opens 
(flexure), blood passes (shear), the valve closes (flexure) and retrograde blood flow is 
prevented (tension) (Fig. 1.4). Due to the higher prevalence of disease and surgical 
repair, most research on HV biomechanics has been carried out on the AV [9, 33, 52-58] 
and MV [59-62]. In healthy individuals, the AV opens during ventricular contraction for 
200-300ms, also known as systole, and closes during ventricular relaxation, diastole, with 
blood flowing through the AV at a peak velocity of 1.35 ± 0.35 m s
-1 
[63]. Valve closure 
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occurs at the end of the deceleration phase of systole with minimal backflow through the 
valve. This motion creates adverse axial pressure differences along in the developing 
boundary layer along the aortic wall, causing the inertial flow in this region to decelerate 
and then, reverse direction, creating vortices in the sinuses behind the AV leaflets. [64].  
The creation of these vortices facilitates the closing and coaptation of the AV leaflets. 
When coupled with the vortices that push the leaflet surfaces towards the closed position, 
this force leads to a very fast and efficient closure of the valve.  
Time dependent behaviors  
 Our group, along with others, [65-67] have conducted biomechanical tissue 
analyses at quasi-static (strain rates of 4%/s to 12%/s) experimental conditions and 
showed that heart valve leaflet deformations can reach strain rates as high as 300%/s, 
raising an important question on the link between HV quasi-static leaflet mechanical 
properties and HV physiology. Although strain-rate dependence has been extensively 
studied in soft-tissue biomechanics, the literature indicates a wide range of findings that 
are dependent on the specific tissue composition and structure as well as the specific 
testing methods utilized to characterize it. Thus, to be able to model physiological 
functions and understand the strain rate dependence of a particular tissue, one needs to 
property investigate it and quantify its mechanical properties under realistic physiological 
loading states. 
As previously mentioned, the fibrosa layer is composed predominantly of a dense 
network of collagen fibers and is thought to be the major stress-bearing layer. Collagen 
fibers have low torsional and flexural stiffness, yet can withstand high tensile forces. As a 
result, fiber orientation can be used to identify directions in which the tissue is able to 
withstand the greatest tensile stresses. In this technique, a laser light is passed through a 
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tissue specimen and is then scattered. The spatial intensity distribution of the resulting 
scattered light represents the sum of all structural information within the light beam 
envelope. To quantify the changes that occur in AV leaflet structure with increasing 
transvalvular pressure (TVP), fresh porcine AVs were fixed at TVPs ranging from 0 to 90 
mmHg and imaged using small angle light scattering (SALS). Overall, increasing TVP 
induced the greatest changes in fiber alignment between 0 and 1 mmHg, and past 4 
mmHg there was no detectable improvement in fiber alignment (Fig. 1.5b-d). 
The method of Hilbert et al. [68, 69] has previously been used to quantify the 
amount of collagen fiber crimp in the native pulmonary and aortic HVs by identifying the 
cross-sectional regions that displayed observable crimp [70].[70] It was found that at 0 
mmHg, approximately 60% of the AV transverse cross-sectional area was occupied by 
crimp structure (Fig. 1.5b). As the TVP increased, the percent crimp decreased rapidly 
until 20 mmHg, with minimal decreases in percent crimp thereafter. For the AV, much of 
the observed change in collagen structure is due to the finely tuned straightening of the 
collagen fibers, which must occur at the right strain level and at the right rate to facilitate 
coaptation without allowing excessive tissue deformations that could lead to 
regurgitation. The unique structure of the commissure region, which approximately 
corresponds to the coaptation region, highlights the adaptive structure of HVs. Instead of 
undergoing TVP differences, the coaptation region is loaded in a uniaxial-like manner 
due to tethering forces generated at the attachment of the commissures to the aortic root. 
Unlike the biaxially loaded belly regions of the valve, the uniaxial loading of the 
commissures makes them more highly aligned, similar to tendon. Fiber uncrimping with 
stress occurs very rapidly for this highly aligned fiber network, as demonstrated by the 
short transition region from low to high stiffness. The highly aligned nature of the 
commissure region at unloaded state and the more rapid realignment with TVP in the 
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commissure regions are consistent with the pre-transition strain level behavior of tendon-
like materials. 
It has been demonstrated that the individual layers of the aortic valve are not only 
vastly different in their structure, but also in their mechanical behavior. Two key studies 
have investigated individual layer behavior of the AV leaflet. Vesely et al. observed the 
extensibility of intact tissue under uni-axial tension to be significantly different from the 
individual layer responses [71]. Stella et al. also observed measurably different behaviors 
under bi-axial loading of separated layers, and reported the intact tissue response to be 
intermediate to the separated responses [72]. Due to these consistently observed 
differences in layer behavior, examining the leaflet in an intact state is far more 
physiologically relevant. Flexural loading of the leaflet allows the leaflet to undergo 
tensile and compressive loading of each layer by bending with and against the natural 
leaflet curvature while still remaining intact. 
Flexural deformation 
Flexure is a major deformation mode of the cardiac cycle [73, 74] and has been 
extensively used for valve tissue mechanical studies [75-79]. Experimental measurements 
of the flexure of soft biological materials has two advantages over tensile mechanical 
testing: 1) the ability to discern very small changes in stiffness at low stress-strain and 2) 
the ability to assess the contributions and interactions of individual layers of multi-
layered structures.  
Thus, multi-layered tissue, such as the AV leaflet is expected to reveal a distinct 
bending response in each direction of bending.  As a result, flexural mechanical testing 
techniques provide a sensitive way to explore the effects of layer-specific contributions to 
the overall biomechanical function of the AV. Our group has used circumferential strips 
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of porcine AV leaflets to quantify the flexural properties of the belly region (Fig. 1.5a) 
and experimental details have been previously reported [75, 78, 80]. It is important to 
note that in the unloaded state, the AV leaflet exhibits a natural curved shape both in the 
circumferential and radial directions. Therefore, the change in curvature  (in units of 
mm
-1
) from the initial unloaded reference state is used to account for the initial curvature 
of the test specimen. Applying bidirectional flexure can subject both the fibrosa and 
ventricularis layers to alternate states of tension and compression (Fig. 1.6a and 1.6b). 
These flexural directions are referred to as “with curvature” (WC) and “against 
curvature” (AC), both of which are with respect to the direction of the natural leaflet 
curvature. The effective stiffness measured in the WC direction is dominated by the 
ventricular tension with little contribution form the fibrillar collagen in the fibrosa, which 
is not designed to support compressive loads. On the other hand, when the leaflet is bent 
in the AC direction, the fibrosa is in tension and the ventricularis is in compression. Data 
from this study shows how the applied bending moment (M) changes with . The Euler-
Bernoulli equation M = EI  [81], where E is the effective stiffness and I the second 
moment of inertia, can then be used to estimate the effective (i.e. total) bending stiffness.  
The moment (M)-change in curvature () response of the AV leaflet was found to be 
linear (Fig. 1.6c and 1.6d). This is due to how tissue layers are loaded and can be 
explained by the micromechanical mechanisms underlying the flexural response, which 
are quite different than those that play a major role in in-plane tension. 
Throughout this body of work, flexural loading is used as the primary mode of 
deformation for all experimental studies. AV leaflets experience complex bidirectional 
flexure in vivo [82, 83], so to simplify the problem, we focused on bending in the 
circumferential direction only, as it is the major curvature change in leaflets [84]. As 
discussed in detail in Chapter 2, an appropriate nearly incompressible hyperelastic 
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constitutive model was selected that captures the macroscopic bending behavior of the 
AV leaflets initially. As the work progressed, this model was modified to incorporate a 
bimodular component, similar to approaches used in modeling other types of fibrous 
tissues. [85, 86]. This enabled the model to capture experimentally observed bidirectional 
differences in the AV bending behavior [75]. 
AV DISEASE AND TREATMENT OPTIONS 
According to Heart Disease and Stroke Statistics—2016 Update published from 
the American Heart Association [87], valvular heart disease accounts for 24,608 deaths. 
Disease of the aortic valve is the most prevalent, accounting for 16,908 of the deaths and 
was a contributing factor in 33,931 cases. The prevalence and incidence of heart valve 
disease will continue to rise with the aging population and rise in life expectancy.  
Calcification is the primary cause of AV failure and currently there exists no 
proven therapy for halting this progression. Calcified aortic valve disease (CAVD) is a 
slow, progressive, multi-factorial disorder that is more common with age, without being 
an inevitable consequence of aging [88-92]. The disease is characterized by a thickening 
and calcification of the leaflets and is diagnosed in two stages: aortic sclerosis (ASc) and 
aortic stenosis (AS). ASc, present in more than 25% of patients over the age of 65 [93], 
represents the early onset of CAVD absent of physical obstruction to the left ventricular 
outflow. Aortic stenosis exists in 2-5% of the elderly population [93] is characterized by 
late stage obstruction and associated with impaired leaflet motion, valve tissue 
adaptation, and resistance to blood flow [94-97]. Although aortic sclerosis causes 
significant thickening of the AV leaflets, there is little to no change in the mechanical 
properties of the valve, making the disease relatively asymptomatic. Recent statistics 
have shown that within 10 years of their initial diagnosis, 10% of aortic sclerotic patients 
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reach a state of severe CAVD that requires immediate AV replacement once symptoms 
emerge [96]. Despite its clinical prevalence, a limited number of studies have 
investigated the active cellular process underlying the progression of this disease. 
Currently, over the last 2 decades research has revealed the disease to be a biologically 
active process with similarities to atherosclerosis but also with several key differences 
[98]. One difference is that the hallmark indicator of atherosclerosis is unstable lipid 
plaque, whereas the hallmark of CAVD is severely progressed calcification that causes 
physical stiffening of leaflets and can lead to physical obstruction (stenosis) of the AV. 
More studies must be done to understand contributing mechanisms such as shear forces, 
genetic factors and regulators of myofibroblast differentiation and osteoblastic 
calcification. Additionally, it is now understood that significant changes occur at the 
structural level, changing the organization, composition and mechanical properties of the 
extracellular matrix (ECM) [99]. The pathological disruption of the AV’s normal 
structure leads to calcification causing the tissue to become thicker and stiffer, ultimately 
leading to a decreased orifice area and thus, stenosis. The resulting abnormal 
biomechanics cause lifelong valvular dysfunction, which will ultimately require surgical 
valve replacement. 
AS has been identified as the end-stage of CAVD that progresses from the 
microscopic early changes of AVSc to, in a subset of patients, asymptomatic and then 
symptomatic AS [91, 100, 101]. Once AVSc is detected (Fig. 1.7), there is an increased 
risk of cardiovascular events, as shown by deviation of the survival curve (purple line in 
Fig. 1.7) from the expected event-free survival (light blue line in Fig. 1.7). In early AS, 
when mild symptoms begin to present, survival rates deviate much more than expected 
and decline dramatically with the onset of severe symptomatic AS. Over the last decade, 
several clinical trials, mostly extensions of atherosclerosis-related studies, have been 
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performed to halt the progression of CAVD with randomized studies showing substantial 
equivalence between treatments and placebo [102-106]. However, there are currently no 
pharmacological therapies available to treat CAVD symptomatic patients that are 
considered superior to full valve replacement surgery. 
In order to impact the progression of the disease, we need to understand both 
subclinical and symptomatic stages so we can measure targeted therapy before aortic 
valve sclerosis proceeds to advanced stages. It is important to link organ-level and tissue-
level stresses to cell response and ultimately, to AVIC mechanotransduction, in order to 
fully understand the function and homeostatic response of the AV to altered local tissue 
stress.  
AV replacements 
Currently, full valve replacement remains the gold standard of care for 
dysfunctioning aortic valves. Since the development of the first replacement valves in the 
1950s [107], significant advancements have been made in the realm of valve 
replacements. In the United States alone, more than 80,000 valve replacement using 
either bioprosthetic or mechanical valves per year and more than 300,000 worldwide 
[108]. There are several types of replacement valves available including transcatheter, 
mechanical, and bioprosthetic replacement valves that are available by Edwards 
Lifesciences, Medtronic, St. Jude Medical, Sorin Group, Boston Scientific and others 
[108].  Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure 
that replaces the aortic valve by wedging a replacement valve into it its place by way of a 
catheter. This novel approach circumvents the need for open heart surgery, providing an 
option for patients who only 10 years ago would be considered high risk surgical 
candidates and been denied surgical intervention. Mechanical valves have evolved 
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significantly since the first ball-and cage design, spanning a variety of shapes sizes and 
materials and rarely experiencing mechanical failure.  Currently, the most common 
mechanical design for an aortic valve replacement is the bileaflet design that consists of 
two semicircular discs surrounded by a sewing ring [108] shown in Fig. 1.8 (Left). 
Despite success with mechanical valve replacement outcomes, patients must rely on 
lifelong anti-coagulation therapy with a vitamin K antagonist to prevent valve-associated 
thrombosis and thromboembolic stroke. However, this can lead to an increased risk of 
major bleeding and other complications such as hemorrhagic stroke [109]. The primary 
advantage of a mechanical valve over a bioprosthetic valve is its durability and is often 
indicated for use in younger patients. The design of mechanical valves is becoming 
increasingly more advanced as we gain a gain a deeper understanding of native valve 
biomechanics and fluid dynamics through both computational model and experimental 
techniques.  
Bioprosthetic heart valve (BHV) replacement options more closely resemble the 
native anatomy of the aortic valve. The most common bioprosthetic option is either a 
three porcine valve leaflet cross linked with glutaraldehyde or bovine pericardium 
(xenografts)  [110] shown in Fig. 1.8 (Right). Less common bioprosthetic options are to 
replace the diseased valve with allografts and autografts without a stent or sewing rings 
[110]. Bioprosthetic replacements have a more flexible and biocompatible surface for 
improved blood flow dynamics which mitigates the need for anticoagulation. BHVs tend 
to have complications over time due to leaflet deterioration and must be replaced within 
15 years in 50% of patients. However, the advantage of using a BHV is it provides a 
more physiologically realistic flow profile and does not require lifelong anticoagulation 
therapy.  
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Ultimately, understanding valve structure and the that exists between scales in 
healthy and diseased valves is an integral component towards the ultimate goal of 
engineering tissue valves that structurally and functionally resemble native valves. Thus, 
it is imperative that fundamental structure-function understanding guides the 
reproduction of native tissue if it is to emulate its native counterpart successfully. The 
complex nature of valve biomechanical behavior and function [1] cannot be duplicated 
with simple homogenous biomaterials. Consequently, to develop replacement valvular 
tissues we must more fully understand the fundamental micromechanics of the tissue in 
both healthy and diseased states.  
CELL-LEVEL MECHANOBIOLOGY  
In biomechanics, the presence of normal tissue stresses is considered to be closely 
related to tissue homeostasis [111-115]. Strong correlations exist between mechanical 
stresses and heart valve biology and have been well documented by clinical observations 
and animal studies [116-120]. Many studies have shown that pathophysiological 
alterations in mechanical loading lead to stress changes and tissue adaptation that affect 
tissue structure and composition [121, 122]. In heart valves, the ECM not only provides 
the tissue with its structural integrity, but it also influences cellular processes through 
three different mechanisms: 1) matricellular, in which the ECM signals through adhesion 
receptors, 2) matricrine, which regulates growth factor and cytokine expression in cells, 
and 3) mechanical, which can be characterized as either matrix elasticity or external 
forces [99]. In mechanical signaling, the ECM can transmit external forces, such as 
stretch, shear stress, and pressure to the cells, but it can also regulate cellular function 
through its intrinsic composition and elasticity. The mechanical interaction of VICs with 
the surrounding ECM, particularly with the collagen fibrils, is fundamental to its cellular 
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response. The intrinsic ECM composition and its importance in modulating cellular 
response are apparent in ultrastructural studies by our group, which reveal the 
micromechanical environment of the cell and highlight the intimate contact between the 
collagen fibrils and the VIC. Collagen fibrils are circumferentially oriented and the VICs 
are aligned along the same direction. In heart valves, pathological factors, such as 
tachycardia-induced cardiomyopathy [123], mitral regurgitation [124], and CAVD [125] 
have been shown to affect valve tissue structure and composition. The link between 
tissue-level deformations and ECM remodeling is essential in understanding 
cardiovascular and in particular, heart valve disease and pathologies.  
AVIC contractility has been qualitatively studied with cultured cells on silicone 
substrates in the presence of multiple contractile chemical agents [45, 126]. In both of 
these studies, contraction occurred for most agents within 3 minutes and reached a 
plateau within 10 minutes. The few cells that did not have an initial basal tonus did not 
respond to the administered vasoconstriction drugs. Isoproterenol was used to elicit 
relaxation from active cells, from which all cells recovered their previous basal tonus 
within 25 minutes. Although they do not provide any quantitative information, these 
findings were the first to demonstrate AVIC contractile response and shed light on VIC 
contractile behavior.  
VIC deformation under physiological loading  
 The extremely low forces generated by AVICs during contraction are unlikely to 
directly affect valvular function. This said, VICs are a dynamic source whose 
biosynthetic capabilities serve an important role in maintaining overall valve leaflet tissue 
homeostasis. In vitro studies of VICs indicate that these cells increase their collagen 
synthesis in the presence of vasoactive agents, suggesting that VICs use their contractile 
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elements to mechanically communicate with the local microenvironment [127]. The local 
stress-strain fields in the vicinity of a cell are dependent on a number of factor, including 
but not limited to, cell shape, orientation, and the relative mechanical properties of the 
cell and the surrounding ECM [128]. Thus, it is not clear how the pressures imposed on 
different sides of the heart translate into local stress on the cells. To link observed valve 
leaflet tissue deformation to cell deformation, our group performed a study on the effects 
of transvalvular pressure (TVP) on AVIC deformation [129]. As described previously 
[53], porcine AV leaflets were fixed under varying pressures and Movat stained 
histological sections were imaged and analyzed. We chose to use AVIC nuclear aspect 
ratio (NAR), defined as the ratio of the length divided as the width, as an index of overall 
cellular deformation. Since the AV leaflets consist of histologically-distinct layers with 
different ECM structural components, we hypothesized that there may be a relationship 
between the valve tissue layer and the resulting deformation experienced by the cells that 
reside within that layer under varying applied transvalvular pressure. Results, which were 
presented as AVIC NAR vs. normalized thickness, indicated that AVIC nuclei underwent 
minimal deformation at low transvalvular pressures (0 and 4 mmHg) and in fact, 
maintained an almost constant level toward the ventricularis layer (Fig. 1.9a). While 
there were no detectable changes under 0 mmHg, fibrosa layer AVICs had a slightly 
higher NAR at 4 mmHg. As expected, high transvalvular pressure (90 mmHg) resulted in 
much higher aspect ratios in AVIC nuclei than the zero- and low-pressure groups, with a 
clear demarcation in the fibrosa layer. It is important to note the magnitude of NAR ~5 at 
90 mmHg, which highlights the profound region-specific cellular deformations that occur 
under physiological pressure levels. These deformations occur very rapidly, within ~75 
ms, further emphasizing the ability to VICs to withstand stress in a dynamic environment. 
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The role of VIC contraction as it relates to valve function remains poorly 
understood. However, it has been established that mechanical forces regulate AVIC 
physiology by modulating their biosynthetic activity. In Merryman et al. [33], it was 
shown that VICs residing on the left side of the heart (MVICs and AVICs) not only 
experience higher transvalvular pressure, but also have a greater measured stiffness 
measured by micropipette aspiration (Fig 10a-b) compared to VICs residing on the right 
side of the heart (TVICs and PVICs). In addition to this finding, the study showed a 
strong correlation between increased VIC stiffness and an upregulation in α-SMA and 
Heat Shock Protein 47 (a molecular chaperone protein involved in collagen production) 
(Fig. 1.10c). By comparing left and right side VICs of the heart, and revealing these 
intrinsic differences in mechanical properties, the substantial influence of the surrounding 
microenvironment on the VICs and the associated biosynthetic activity is quite apparent. 
To further drive home the significance of the VIC microenvironment we turn to a similar 
study also my Merryman et al. [130]. The stiffness of AVICs and PVICs were compared 
using a different ex-situ measurement technique, atomic force microscopy. Observed 
differences between the VICs on each side of the heart were found to be the same as 
reported from micropipette aspiration (approximately a two-fold increase in stiffness for 
AVICs), however the magnitude of the stiffness measurements were approximately 10 
fold higher than the micropipette values. This discrepancy between measurements taken 
of non-adherent VICs (micropipette) and VICs seeded on a 2D substrate (AFM) further 
illustrates the substantial influence of the VIC microenvironment on measured properties. 
Currently, the only means of measuring the mechanical properties of VICs, or any other 
cell, is through ex-situ techniques, such as the above mentioned micropipette aspiration 
and atomic force microscopy, that are not representative of the native VIC 
microenvironment as they require physical removal of the cell from its native tissue. 
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Ex-situ methods of measuring cell stiffness 
Micropipette Aspiration  
Micropipette aspiration (MA) is used on live cells to evaluate their time-
dependent deformation under a uniform pressure.  The cell is taken up into a glass tube 
with a chosen inner diameter in a step-wise fashion. The typical range for applied 
pressure is 0.1-1000 Pa and has a claimed resolution of 0.1Pa. The exerted pressure is 
maintained for varying time durations and the extension of the cell in the tube and 
displacement of the membrane are monitored using optical and light microscopy 
respectively. The cells are unable to adhere to the inner pipette wall as they are coated 
with 1% agar. The exerted pressure and whole-cell deformation are then correlated using 
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is the ratio of cell velocity in the presence (𝑥𝑝
′ ) over the absence (𝑥𝑎
′ ) of applied pressure.  
An appropriate viscoelastic model is then needed to calculate the elastic modulus and 
apparent viscosity of the cell membrane as well as the time constants for 
deformation/relaxation.  
Atomic Force Microscopy (AFM)  
Atomic Force Microcopy (AFM) is a specific type of scanning probe microscopy. Images 
are created by a local application of mechanical force across the sample’s surface using a 
sharp tip positioned normal to the flexible cantilever. The cantilever tip displacement is 
tracked by a laser that reflects off the back surface of the cantilever onto a photodiode. 
The voltage is then converted into displacement. This technique is said to give Angstrom-
scale accuracy and allows the advantage of imaging and mechanical stimulation 
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simultaneously. A distinction to note with AFM is that it is performed on adherent cells 
opposed to micropipette aspiration, which is performed on free-floating cells. 
Measurable AVIC changes in-situ 
The flexural mechanical testing techniques described earlier are sensitive enough 
to explore the effects of cellular contraction on leaflet mechanical properties. These 
techniques were used by several groups, including our own, to investigate regional and 
directional receptor-mediated contractile response of AV leaflet tissue [131, 132]. As 
described previously [133], circumferential strips of porcine AV leaflets were 
mechanically tested under flexure in both the WC and AC directions in a normal state, 
under contraction (induced by potassium chloride), and without contraction (i.e., 
contraction inhibited by thapsigargin).  Results revealed a 48% increase in leaflet 
stiffness with AVIC contraction when bent in the AC direction (p = 0.004) and only a 5% 
increase when bent in the WC direction (not significant) in the active state (Fig. 1.6b). 
The thapsigargin treated group (contraction-inhibition) experienced a 76% (p = 0.001) 
and a 54% (p = 0.036) decrease in leaflet stiffness, in the AC and WC directions 
respectively at 5 mM KCl levels. Contraction was completely inhibited with the addition 
of 90 mM KCl as expected (Fig. 1.6c). This bidirectional difference in observed bending 
behavior is indicative of varying ECM mechanical properties between the layers as well 
as possible differences in AVIC connectivity throughout the layers. While these results 
demonstrate that AVIC contractile ability is a significant contributor to AV leaflet 
bending stiffness, its complete role in maintaining AV leaflet tissue homeostasis has yet 
to be elucidated. The most important finding from this work was that AVIC contractility 
is not only contributing to AV bending stiffness, but flexure testing is a valuable tool for 
measuring these changes at the tissue level. The limitation is that these changes are 
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simply observed at the tissue level. To assess changes at the AVIC level, this 
experimental tool must work in a cohesive manner with computational modeling to map 
down to the micro-scale. 
 COMPUTATIONAL MODELING APPROACHES IN BIOMECHANICS 
Computational modeling is a valuable tool for investigating the mechanics the 
heart valves. Due to complex valve anatomy and dynamic biomechanics, there exists no 
standard approach. As Malvern (1969) once described, a continuum-based constitutive 
relation describes the gross behavior of a material, which results from its internal 
constitution, in response to applied loads [134]. However, it is important to recognize that 
there exists no single ideal constitutive relation that will describe all possible behaviors of 
a material under all possible conditions. All heart valves exhibit highly non-linear stress-
strain relationships, large deformation, viscoelasticity and poorly understood coupling 
behavior that is difficult to capture using simple experimental methodology and 
traditional material models. Extensive constitutive material models, including more 
advanced structural material models, have been developed that effectively capture the 
broad spectrum of material properties of biological soft tissue [135, 136] in general and 
valve specific behavior under different loading configurations relevant to the cardiac 
cycle [136, 137]. To solve the complex governing equations that dictate valve solid 
mechanics, a discretization must be employed and solved using a numerical approach. In 
the field of solid mechanics, the finite element (FE) is the most commonly utilized 
approach, and the method utilized in this dissertation.  
A variety of different methods have been developed for studying different aspects 
of valvular behavior including but not limited to varied anatomical parameters, different 
portions of the cardiac cycle, fluid dynamics and different material characteristics. In the 
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past two decades, many groups have conducted intensive research on predictive heart 
valve computational models. Advances in numerical modeling and experimental 
biomechanics have enabled these newly developed models to become increasingly 
comprehensive and accurate. For the MV for example, studies have included 
development of constitutive models [138-142], image-based patient-specific 
computational models [143-146], fluid-structure interaction modeling [147, 148], inverse 
models that enable the assessment of the in vivo biomechanical properties [149, 150], and 
coupled modeling of the left ventricle and MV for investigating ischemic MR [151]. For 
example, Einstein et al. modeled the transient vibrations of the MV by constructing a 
dynamic nonlinear fluid-coupled finite element model of the valve leaflets and chordae 
tendineae [147, 152]. The application of physiological pressure loads results in valvular 
movement and small-scale acoustic vibrations of the valvular structures. Material 
changes that preserved leaflet anisotropy were found to preserve overall valve function. 
On the other hand, material changes that altered leaflet anisotropy had a profound effect 
on valvular function. These changes were manifested in the acoustic signatures of the 
valve closure sounds. Abnormally, stiffened valves closed more slowly and were 
accompanied by lower peak frequencies.  Driessen et al. [153, 154] developed a finite-
element (FE) model that relates changes in collagen fiber content and orientation to the 
mechanical loading condition within engineered heart valve constructs, hypothesizing 
that collagen fibers aligned with principal strain directions and that collagen content 
increased with fiber stretch. Results from this study indicate that the computed preferred 
fiber directions are very similar to experimental data from native aortic heart valves. 
Although these models are a step towards the development of more physiologically 
relevant models of heart valve structure and function, there is a still a need for true 
dynamic models that couple tissue (solid) and blood (fluid) and include cell-level 
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interactions. This said, investigators face theoretical, computational, and experimental 
challenges that makes this a difficult feat.  
INTEGRATED COMPUTATIONAL-EXPERIMENTAL APPROACHES IN BIOMECHANICS 
As in all areas of scientific investigation, experimental data are necessary and 
must be used to acquire data on the heart valve response to different stress levels at all 
size scales.  When integrated with computational models, it can provide unique insights 
into the function and physiology of heart valves and provide a powerful platform that can 
generate confirmable predictions of heart valve physiological behavior and ultimately, 
link organ-level and tissue-level deformations to cellular responses. Computational 
models that are linked to experimental data are formed during three distinct phases in the 
model development process: observation, fitting, and validation [155]. Below are two 
examples of this approach from our research group, in addition to the work presented in 
this dissertation. 
Layer specific MVIC-ECM coupling. More recently, several groups have linked 
tissue-level induced stress and the resulting MV interstitial cell (MVIC) deformation to 
abnormal biosynthetic activity that can lead to reduced tissue-level maintenance and 
subsequent organ-level failure. To link tissue-level loading and cellular response and 
thus, gain more insights into MVIC mechanobiology, an integrated experimental-
computational approach was developed that informs us on MVIC biophysical state. First, 
the in situ layer-specific MVIC deformation were quantified for all four layers of the MV 
under controlled biaxial tension using a biaxial stretching device that is coupled to a 
multi-photon microscope [156] (Fig. 1.11). Then, a macro-micro finite element 
computational model was used to explore the relationship between layer-specific 
mechanical and structure properties and MVIC stiffness and deformation. The 
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experimental results indicate a significantly larger deformation in both the ventricularis 
and fibrosa layers of the MV compared to the spongiosa and atrialis layers, with a nuclear 
aspect ratio as high as 3.3 at the maximum physiological tension of 150 N/m. The 
simulated MVIC moduli however were found to be relatively similar and within a narrow 
range of 4.71–5.35 kPa (Fig. 1.12 and 1.13). This is an important finding that suggests 
that MVIC deformation is controlled by the structure and composition of the 
microenvironment rather than intrinsic cellular stiffness. From this finding, it can be 
concluded that while MVICs may phenotypically similar throughout the layers of the 
leaflet, they experience different mechanical stimuli from the layer-specific 
microenvironment in which they reside.  
Isolated VIC behavior. We recently developed a novel solid-mixture model for 
VIC biomechanical behavior that captures the modulating mechanical responses of VICs 
resulting from different activation sates and loading conditions [157]. One major driver 
for this study was the 100-fold disparity, indicated earlier, between the micropipette and 
AFM VIC moduli observed, where the micropipette estimated a ~0.5 kPa modulus (Fig. 
1.10) while the AFM exhibited a ~50 kPa modulus (Fig. 1.14b).  While differences in 
experimental loading configurations may account for some of the observed differences, 
the major discrepancies in activation states (MA – inactivated, AFM – highly activated) 
are likely the major underlying cause. 
To explore this hypothesis, we developed the following model, which 
incorporated: (1) the underlying cytoskeletal network, (2) the α-SMA stress fibers, and 
(3) a finite deformable elastic nucleus. In order to handle the material and geometric 
nonlinearity, we implemented the model in a 3D finite element simulation and calibrated 
the model parameters using combined mechanical responses of VICs in both micropipette 
aspiration (MA) and atomic force microscopy (AFM) experiments [33, 130] (Fig. 1.14). 
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We then used the resulting model to examine the mechanical responses of both aortic and 
pulmonary VICs (AVICs and PVICs, respectively) in both their inactivated states (during 
MA experiments) and activated states (during AFM experiments) (Fig. 1.15).  
The resulting simulation indicated that AVICs exhibit 9 to 16 times stronger 
intrinsic contractile responses to PVICs, highlighting the model’s ability to predict the 
cellular stiffening that is caused by the underlying α-SMA fiber contraction (Fig. 1.16). 
We used the same model to calculate traction forces exerted by the VICs on the substrate 
and found good agreement with previously reported traction force microscopy results. 
The estimated nuclear stiffness for both AVIC and PVIC were similar and comparable to 
the literature, and were unaffected by VIC activation level. Results from this study 
highlight that in inactivated states, the α-SMA fiber stiffness is the main contributor of 
the underlying cytoskeletal stiffness, suggesting that any increases that are seen in VIC 
stiffness when it changes from inactive to active state are due to the contraction of the α-
SMA fibers. Although we chose to follow a continuum approach, such a model can be 
easily incorporated into a multiscale model of the heart valve, wherein the multi-scale 
model is used to answer important questions on the mechanics and mechanobiology of 
heart valve disease and surgical repair.  
MOTIVATION, RATIONAL, AND SPECIFIC AIMS 
As demonstrated in the preceding sections, AVICs are tightly coupled with the 
surrounding ECM. The necessity of maintaining VIC-ECM coupling in actin-mediated 
VIC force generation has been demonstrated in mitral valve leaflets [51] and likely exists 
in AV tissue as well. The ability to assess AVIC responses in situ can lead to further 
understanding of AVIC-ECM mechanical coupling in response to physiological 
conditions synonymous with valvular disease. The thinness of the valves allows the 
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stimulation of underlying AVICs with chemical cues [158-160], making the AV an ideal 
platform for in situ investigation. While advances have been made toward the 
understanding of isolated AVIC behavior (ex situ), the AVIC biomechanical state 
(specifically stiffness and contractile state) in its native microenvironment remains 
largely unknown. Consequently, changes in AVIC stiffness and contractility resulting 
from pathological conditions in situ remain unidentified. This suggests a need for novel 
methods that maintain this coupling for probing the effects of mechanical and 
chemical stimuli on AVIC biomechanical state. 
To address the need for an in situ estimation tool of AVIC biomechanical state, a 
novel integrated computational-experimental approach was developed. Specifically, a 
computation model was developed and paired with biomechanical experiments to probe 
AVIC stiffness and contractility responsiveness in normal and TGF-β1 treated AVs. To 
provide both validation of an in situ approach and further insight, microindentation 
studies of ex-situ cultured AVICs were carried out. Computational models provide a 
means of investigating experimentally acquired data from in vitro, in situ and in vivo 
methods. Taken independently, theoretical simulations are only as accurate as the 
information we provide them and are often limited by insufficient availability of data. 
Similarly, experimentally acquired data is often difficult to interpret without the aid of 
mathematical theory. Taken in cohort, an integrated computational-experimental 
approach can be used to more accurately interpret experimental findings and push 
computational models even further in their biological accuracy. 
The primary goal of the integrated computational-experimental approach is 
to estimate AVIC biomechanical state while maintaining layer-specific native AVIC-
ECM mechanical coupling. Predicting the biomechanical state of AVICs in situ 
provides a significant advantage in that they remain in the native microenvironment, 
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maintaining essential AVIC-ECM coupling. We hypothesize that deriving the 
biomechanical state of AVICs in situ will reveal more accurate information regarding 
AVIC adaptations to various stimuli. By studying the AV under flexural deformation, 
layer-specific information regarding AVIC responses can be obtained. Such an approach 
can reveal important changes resulting from pathological states and corresponding 
pharmaceutical interventions. This research approach will be addressed using the 
following specific aims: 
Specific Aim 1. Develop a model of the AV leaflet that captures non-viable tissue 
level behavior  
An integrated experimental-computational investigation utilizing flexural deformations of 
intact AV leaflets will be used as a means to probe layer interactions. This will inform us 
of individual layer contributions to observed bending in the AV. Parametric simulations 
of layer interactions will be conducted using a tri-layered leaflet tissue finite element 
(FE) model to simulate interlayer sliding hypothesized to occur. To validate these 
findings and further refine the model, experimental studies on porcine AV leaflet tissue 
will be conducted to examine the bi-directional flexural response, and relative interlayer 
movement using actual transmural strain responses.  
Specific Aim 2. Develop and validate a micro-anatomically realistic macro-micro FE 
model to estimate in situ AVIC mechanical behavior under activation. 
As a first step to developing the model of the normal AV, the non-viable tissue model 
developed in SA 1 will be extended to formulate a macro-micro FE model to simulate 
mechanical behavior of viable AVICs under activation. This provides a novel method of 
extracting AVIC mechanical properties in their native in situ environment by utilizing 
flexure experimental data. The role the AVIC-ECM connection plays in the AV tissue 
response at different activation states will assessed.  
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Specific Aim 3. Measure the layer dependent contractile response of AVICs in situ 
using the developed macro-micro model in a simulated pathological state and 
validate measured responses against microindentation experiments. 
To understand differences in AVIC contractile responses due to varied layer connectivity, 
AVIC contractile responses were measured in-situ using novel experimental 
biomechanical studies performed with normal and TGF-β1 (pathological) treated porcine 
AV tissue under flexural loading. The multi-scale FE model developed in SA 2 was used 
to evaluate how TGF-β1 affects tissue level bending behavior in the AV due to changes 
in underlying AVIC-ECM coupling and AVIC stiffness. Finally, microindentation studies 
examining AVIC activation will be run in parallel with in situ studies to validate the in 
situ approach. We hypothesize that observed differences between ex-situ and in-situ 




Figure 1.1: Schematic depicting the location of the four heart valves (mayoclinic.com). 
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Figure 1.2: A schematic approach to the biomechanics and mechanobiology of heart 
valve function. Heart valve function can be divided into multiple length 
scales: organ-, tissue-, cell-, and sub-cell levels. 
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Figure 1.3: Layered architecture of the Aortic Valve illustrated at its attachment [2] to 
the aorta  and a more detailed illustration of the various constituents of the 
leaflet layers adapted from [161]. 
 
 
Figure 1.4: Blood flow across the aortic valve adapted from [161]. 
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Figure 1.5: (a) Diagram of the AV cusp highlighting the belly, commissures, nodulus, 
and regions of coaptation. Small angle light scattering results with the 
orientation index at (b) 0mmHg, (c) 4mmHg, and (d) 90mmHg transvalvular 
pressure. No further changes in fiber alignment were observed past 4mmHg. 
These results are consistent with histological-based data that quantifies the 
percent area of tissue displaying collagen fiber crimp (e). Adapted from 
Sacks et al. [53]. 
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Figure 1.6: (a) Schematic showing the region of tissue used for bending tests in the AV. 
(b) Schematic showing directions of bending for the AV with respective 
layers (V: ventricularis, S: spongiosa, and F: fibrosa). M vs. Δκ relations in 
both the AC and WC directions for (c) specimens tested in 5 mM and 90 
mM KCl, and (d) specimens flexed in 5 mM KCl and samples treated in 10 
µM thapsigargin overnight and then flexed in 5 mM KCl. While the 
application of 90 mM KCL induced an increase in stiffness in the AC 
direction only, both bending directions experienced a loss of stiffness with 




Figure 1.7: Progression of CAVD (modified from Otto et al. [162] and Rajamannan et 
al. [161]). The spectrum of disease ranges from the ‘at risk‘ patient to the 
patient with end-stage severe symptomatic aortic stenosis. The light blue 
line represents the expected event-free survival and the purple line 
represents the survival curve at the onset of aortic sclerosis, which deviates 
from the expected survival line. Atherosclerotic risk factors involved in the 
development of aortic valve disease from aortic sclerosis to calcified aortic 




Figure 1.8: Left: Medtronic Open Pivot Mechanic Valve (www.medtronic.com) Right: 
St. Jude Medical Epic Stented Valve (www.sjm.com).  
 
Figure 1.9: (a) The relation between AVIC nuclear aspect ratio (NAR) and transvalvular 
pressure loading, with values reported over normalized leaflet thickness. (b) 
AVIC NAR vs. the normalized collagen fiber orientation index (NOI) at 
different transvalvular pressure levels. These results suggest that AVICs are 
not appreciably loaded until the collagen fibers fully straighten at 




Figure 1.10: (a) A VIC under micropipette aspiration – the vertical bar represents the 
aspiration length. (b) Functional correlations of effective cell stiffness E vs. 
transvalvular pressure. (c) Linear correlation between Hsp47 vs. α-SMA, 
showing a strong correlation between the two proteins (r = 0.996) as the one 
progresses from the right to the left side of the heart. 
 
Figure 1.11. Transmural MVIC distribution and deformation in the mitral valve anterior 
leaflet under controlled biaxial loading. (a) Stack of two-photon excited 
fluorescence images. Red represents collagen fibers and green represents 
cell nuclei stained with Cytox Green. Image-stacks were processed and used 
to quantify cellular deformation by measuring the nuclear aspect ratio 
(NAR) (b) Measured layer-specific NAR as a function of membrane tension.  




Figure 1.12. The macro-micro finite element (FE) model used to investigate MVIC 
deformation. (a) Schematic diagram of the tissue-level model: the region of 
interest of the MVAL tissue under equibiaxial tension loading. (b) Diagram 
of the cell-level microenvironment model, which consists of 37 uniformly 
distributed MVICs embedded in the layer-specific representative volume 
element. The tissue-level deformations are used to prescribe boundary 




Figure 1.13. Comparisons of the experimentally measured and numerically predicted 
NARs as a function of tissue-level tension: (a) atrialis layer (r
2
 = 0.8403), 
(b) spongiosa layer (r
2
 = 0.9166), (c) fibrosa layer (r
2
 = 0.8906), and (d) 
ventricularis layer (r
2
 = 0.9373). Adapted from Lee et al. [163]. 
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Figure 1.14. (a) Schematic of the AFM experiment, showing how the VIC rests on a 
collagenous surface and expresses α-SMA. (b) Reported effective moduli of 
AVIC and PVICs, which were ~100 fold larger than the equivalent 
micropipette results.  (c) AFM simulation setup with finite element mesh. 
The mesh was refined around the indentation region, with typically 
10,000~50,000 linear tetrahedron elements. Note that this is a cross-section 
of the geometry, but we simulated the whole cell. Adapted from Sakamoto 
et al. [157]. 
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Figure 1.15. The step-by-step calibration process. 1. The cytoskeletal shear modulus 
(μcyto) and α-SMA fiber shear modulus (μsf) were calibrated using the 
micropipette aspiration data for different types of VICs with different 
expression levels of α-SMA fibers. 2. Using the AFM indentation data on 
the cell peripheral regions, the fiber active contraction strength (f) was 
calibrated for AVICs and PVICs. 3. Using the AFM indentation data on the 
cell central region, the shear modulus of nucleus (μnuc) was calibrated for 
AVICs and PVICs. The parameters in red represents the ones that are being 
calibrated in the step, the parameters in gray represents the ones that are 
assumed not contribute to the mechanical response of the VICs (hence 
ignored) in the step, and the parameters in black represents the ones that are 
already calibrated from the previous steps and integrated into the model. 




Figure 1.16. (a) Contraction strength of the α-SMA fibers in the AVICs and PVICs. 
About 9:1 ratio in the contraction strength was observed from AVICs to 
PVICs. (b) Shear moduli of the AVICs and PVICs nuclei, which exhibited 
no differences. Adapted from Sakamoto et al. [157]. 
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CHAPTER 2: INTERLAYER MICROMECHANICS OF THE 
AORTIC HEART VALVE LEAFLET 
Preface 
While the mechanical behaviors of the fibrosa and ventricularis layers of the 
aortic valve (AV) leaflet are understood, little information exists on their mechanical 
interactions mediated by the GAG-rich central spongiosa layer (Fig. 2.1a-b). Parametric 
simulations of the interlayer interactions of the AV leaflets in flexure utilized a tri-
layered finite element (FE) model of circumferentially oriented tissue sections to 
investigate inter-layer sliding hypothesized to occur. Simulation results indicated that the 
leaflet tissue functions as a tightly bonded structure when the spongiosa effective 
modulus was at least 25% that of the fibrosa and ventricularis layers. Novel studies that 
directly measured transmural strain in flexure of AV leaflet tissue specimens validated 
these findings.  Interestingly, a smooth transmural strain distribution indicated that the 
layers of the leaflet indeed act as a bonded unit, consistent with our previous observations 
[1] of a large number of transverse collagen fibers interconnecting the fibrosa and 
ventricularis layers.  Additionally, when the tri-layered FE model was refined to match 
the transmural deformations, a layer-specific bimodular material model (resulting in four 
total moduli) accurately matched the transmural strain and moment-curvature relations 
simultaneously. Collectively, these results provide evidence, contrary to previous 
assumptions, that the valve layers function as a bonded structure in the low-strain flexure 
deformation mode.  Most likely, this results directly from the transverse collagen fibers 
that bind the layers together to disable physical sliding and maintain layer residual 
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stresses. Further, the spongiosa may function as a general dampening layer while the AV 
leaflets deforms as a homogenous structure despite its heterogeneous architecture1. 
INTRODUCTION 
To date, only two studies have investigated the mechanical behavior of individual 
leaflet layers using micro-dissection techniques. Vesely et al. observed the extensibility 
of intact tissue under uni-axial tension to be significantly different from the individual 
layer responses [2]. In the second study, Stella et al. observed measurably different 
behavior under biaxial loading of the separated layers [1]. The intact tissue response was 
intermediate to the separated responses. Interestingly, it has been assumed previously that 
the spongiosa layer enables sliding between the fibrosa and ventricularis during opening 
and closing [3-7], yet little data exists to support this theory. Vesely and Boughner (1989) 
and Song et al. (1990) claim evidence of measured sliding between the layers; however, 
the loading conditions used were artificial and not representative of physiological flexural 
conditions. Thus, the degree of bonding that exists between the two layers and its effects 
on AV leaflet bending in vivo remains unclear. Moreover, based on these findings, it is 
apparent that the individual layers function quite differently in the intact configuration 
than separated and must be evaluated in the intact state. 
Historically, the term “tissue engineering” is attributed to Y.C. Fung [8]. The term 
underscored the importance of “the application of principles and methods of engineering 
and life sciences toward a fundamental understanding of structure-function relationships 
in normal and pathologic mammalian tissues and the development of biological 
                                                 
1 Portions of this chapter have been previously published in Biomechanics and Modeling in 
Mechanobiology (Interlayer micromechanics of the aortic heart valve leaflet, vol. 13, pp. 813-26, 2014). 
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substitutes to restore, maintain, or improve tissue function.” Thus, it is imperative that 
fundamental structure-function understanding guides the reproduction of native tissue if it 
is to emulate its native counterpart successfully. Clearly, the complex nature of valve 
biomechanical behavior and function [9] cannot be duplicated with simple homogenous 
biomaterials. Consequently, to develop replacement valvular tissues we must more fully 
understand the fundamental micromechanics of the tissue in both healthy and diseased 
states [10].  
In the present study, we conducted an integrated simulation-experimental 
investigation utilizing flexural deformations of intact AV leaflets as a means to probe 
interlayer interactions. In addition to being a natural choice to study interlayer 
micromechanics, flexure is a major deformation mode of the cardiac cycle [11, 12] and 
has been extensively used for valve tissue mechanical studies [13-17]. Parametric 
simulations of interlayer interactions were first conducted using a tri-layered leaflet tissue 
finite element (FE) model to simulate interlayer sliding hypothesized to occur. To 
validate these findings and further refine the model, experimental studies on porcine AV 
leaflet tissue were conducted to examine bi-directional flexural response, and relative 
interlayer movement using actual transmural strain responses.  
METHODS 
The flexural deformation mode not only represents a major deformation mode of 
heart valve leaflets, but also allows direct examination of individual layer responses in 
tension and compression. It should be noted that AV leaflets experience complex 
bidirectional flexure in vivo [18, 19]. To simplify the problem, we focused on bending in 
the circumferential direction only, as it is the major curvature change in leaflets [20]. A 
circumferentially oriented rectangular leaflet tissue strip configuration, located below the 
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Nodulus of Arantius (Fig. 2.2-a), was used for simulation since the central belly region is 
structurally most representative of the leaflet [21]. First, an initial model was used to 
conduct a parametric study of the deformation through the thickness of the leaflet at 
varying degrees of layer connectivity. The results of this model were verified with novel 
experimental flexure studies that quantified the transmural variations in transmural strain. 
Based on these results, a refined flexural model was then developed to simultaneously 
match the moment-change in curvature (M-Δκ, where  = -0 and 0 the initial 
curvature) relationship and transmural deformation of the AV in both bending directions. 
The end result was a clearer picture of interlayer mechanical interactions of the low strain 
behavior that occurs in flexure.  
Initial simulations of AV leaflet tissue flexure 
A finite element (FE) model was developed to simulate AV leaflet tissue in 
flexure using the software package COMSOL Multiphysics v4.3 (Burlington, MA). A 
rectangular model geometry was used, set to 14 mm in length (circumferential direction) 
by 3 mm in width (radial) by 0.4 mm thick. The tissue layer geometry was derived on 
previous histological data [22], which showed that the fibrosa represented 45% of the 
volume, the spongiosa 30%, and ventricularis 25%. Boundary conditions simulating 
three-point bending were avoided to ensure no point-loading effects would occur in the 
center of tissue and end-loading conditions were used instead. The boundary conditions 
thus consisted of pins at both ends of the model tissue, and a horizontal load was applied 
at one pin in the X1 direction, causing the model tissue to undergo transverse deflection 
(Fig. 2.2-b). The mesh consisted of 3612 8-node brick elements, and shape functions for 
pressure (linear) were set to one order lower than displacement (quadratic) to avoid 
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locking. The geometry was modeled as symmetric along the X3 axis to decrease 
computing time (Fig. 2.2-b). 
To establish both the material model and to obtain an initial set of material 
parameters, we began with previously published AV flexure data for inactivated tissues 
[9, 13]. The following Ogden model, assuming incompressibility, was chosen as it 
















p − 3)N=1p=1         (2.1) 
where α is a constant, μ the shear modulus, and λ1 and λ2 are the principle stretches. 
When α = 2 and N=1, Eq. 2.1 will simplify to the standard neo-Hookean form. The 
classic analytical solution of an incompressible isotropic beam under flexure [23] was 
used to establish an initial material model for a homogenized single layer beam from Eq. 
2.1. This was accomplished by matching the non-linear shape of the M-Δκ relationship of 
the leaflet bending data to the Ogden model analytical solution from a straight to circular 
beam (Fig. 2.3).  
Interlayer bonding simulation 
To simulate the effects of various levels of interlayer bonding, the following 
parametric simulation was performed. The fibrosa and ventricularis moduli were set to 45 
kPa based on the prediction of the initial flexure simulation described above. Next, 
bending simulations were performed up to curvature changes of 0.1, 0.2 and 0.3 mm
-1
 
with values for the spongiosa shear modulus μ𝑆 varied.  A value of 1 Pa represented 
relatively unbonded fibrosa and ventricularis layers; then μ𝑆 was assigned increasing 
values (μ
S
= 0.1-10 kPa) to simulate increasing levels of bonded states. Lastly, the 
spongiosa was assigned the same layer properties as the fibrosa and ventricularis to 
represent a perfectly bonded state. The deformation gradient tensor was derived from the 
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The resulting deformation gradient tensor F was decomposed into stretch and rotation 
tensors, U and R, respectively. The transmural variation in total axial stretch, 
Λ1=√U11
2 +U12
2 , with respect to the thickness of the tissue was used to determine the 
overall effects of bonding on transmural deformations. Normalized thickness was defined 
with the ventricularis at the origin and the fibrosa at unity.  
Transmural strain experimental validation studies 
 A custom device performed flexure tests on AV leaflets, described in 
detail in [24]. Briefly, two optical systems simultaneously collect flexural rigidity and 
transmural deformation data. A macro imaging system tracks markers on one edge of the 
sample. From these markers the curvature was calculated as well as the applied load via a 
marker on the bending bar transverse linkage. On the opposite edge of the sample a micro 
imaging system employs micron-sized ink marks to determine transmural strain via post 
processing techniques. A specially designed tank and tissue holder maintains placement 
and physiological conditions of the sample being tested. 
Native porcine aortic roots were removed from hearts obtained from an abattoir 
within three hours of sacrifice.  Leaflets were dissected from the root along their 
attachment points, and cut into a circumferentially oriented rectangular strip of tissue for 
testing using a fresh razor blade to ensure smooth flat surfaces in the reference state (Fig. 
2.2-a). On average, specimens were 318±46 microns thick, 13.7±2.1 mm long, and 
2.8±0.2 mm wide [24]. Five small red ink markers were created on the side of the tissue 
farthest from the free edge for curvature calculation using the macro imaging system 
(Fig. 2.2-c). Airbrushing the edge of the tissue opposite to the red macro markers using a 
Badger Sotar airbrush (Badger Air-Brush Co., Franklin Park, IL) and black India ink 
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created microscopic markers for tracking with the micro-imaging system (Fig. 2.2-d). A 
stainless steel sleeve was glued to one end of the tissue using cyanoacrylate and then 
slipped onto a steel dowel to allow for free rotation and restricted translation of the tissue. 
The tank-tissue holder assembly was mounted to a bi-directional (X1 axis movement) 
stage fitted with two precision linear actuators (model MM-4M-EX80, National Aperture 
Inc., Salem NH). A small amount of cyanoacrylate glue attached a second stainless steel 
sleeve to the loading end of the tissue; this sleeve then slipped over a vertically mounted 
316V stainless steel bending bar of known stiffness. The stiffness of the bar determined 
the amount of force produced as a function of the bar’s displacement, eliminating the 
necessity of load cells.  Actuation of the bi-directional stage in the X1-direction moved 
the entire tank and sample, causing the transverse linkage to bend the bending bar. In this 
design, both positive and negative changes in curvature could be tracked, allowing a 
single-run experiment in both the with-curvature (WC) and against-curvature (AC) 
testing directions. 
For the bending data, the following information was recorded for the duration of 
the experiment: coordinates of red macro markers, displacement of the bending bar, and 
the current curvature of the tissue.  Analysis of the bending data was detailed by [25] and 
summarized here.  A custom-written Mathcad (PTC, Needham, MA) program computed 
curvature, change in curvature, and moment at the middle five markers for each time 
point of the experiment.  The resulting marker positions were fit to a fourth-order 
polynomial so that the curvature of the tissue could be determined.  The initial curvature, 
0, was recorded by the control system and subtracted from consequent curvature 
measurements to obtain the change in curvature  = -0. 18 specimens were tested to a 
curvature change up to 0.3 mm
-1
 based on recent in vitro measurements [20]. For clarity, 
results are reported for a change in curvature of 0.2mm
-1
. The moment was determined by 
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using the position of the central marker and the displacement of the bending bar (Eq. 2.2 
and Fig. 2.2-b)  
M = P y          (2.2) 
where M is the applied moment, y is the deflection from the horizontal axis, and P is the 
axial force. The displacement of the bending bar was tracked in real-time since the 
applied axial force, P, was a function of the displacement.  The deflection, y (Fig. 2.2-b) 
was computed using the spatial y coordinate of the central tissue marker and the y 
coordinate of the horizontal axis drawn from post to post. The resulting data is reported 
as the averaged M/I vs. Δκ response of the 18 specimens to normalize with respect to 
specimen geometry. 
To determine transmural deformation, captured images from the micro-imaging 
system that tracked the markers on the edge of the tissue were analyzed (Fig. 2.2-d). A 
telecentric lens was used to avoid loss of accuracy from taking measurements from 
surface bending, resulting in surfaces not orthogonal to the imaging system, on the strain 
measurements. From the macro-level images, LabVIEW software (National Instruments, 
Austin, TX) identified and numbered markers and stored their centroidal coordinates. For 
the micro images used to determine the transmural stretch, an image-based particle 
tracking strain-mapping method, detailed in [26], computed the local deformation 
gradient F over the imaged region. Briefly, the reference and deformed states determined 
the displacement field and were fitted to obtain F. Rigid body deformation was removed 
using polar decomposition. The particle tracking method was shown to measure stretch as 
small as 1.001 with 0.05% net accuracy [24]. The location of the neutral axis was 
determined by plotting Λ1 against the thickness of the tissue to determine the location 
where Λ1=1. 
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Validation of experimental/simulation method 
Validation studies were carried out with 1 mm thick silicone rubber sheets cut 
into rectangular strips of the same dimensions as the experimental studies described 
above, 14mm in length by 3 mm in width. The shear modulus of the strips was 
determined using tensile testing with a MTS Tytron 250 Mechanical Test System and in 
flexure using the same custom flex device. The estimated shear moduli values obtained 
from the three methods were compared to ensure accuracy of both the computational and 
experimental methods. 
RESULTS 
Initial tissue material model 
The resulting M-Δκ relation from the analytical solution was normalized to the 
maximum achieved moment at a curvature of 0.28 mm
-1
, the maximum observed 
experimentally measured value. Although there was some variation with applied moment, 
we determined that a value for  of ~2.0 captured the shape of the M-Δκ (Fig. 2.3, r
2
= 
0.93). It is important to note that the analytical solution utilized a single layer and 
simplified boundary conditions [23], and was thus only used to set the value of the  
parameter. Based on these results, we returned to the isotropic incompressible 




(I1-3) - p(I3-1)         (2.3)  
where I1 and I3 are the first and third invariant of the left Cauchy-Green deformation 
tensor C=F
T
F, respectively, p is the Lagrange multiplier to enforce incompressibility, and 
L indicates the layer (L=F,S, or V).  With this model a value of L = 45 kPa fit the data 
well (0.974) and was used for the fibrosa and ventricularis layers in the unimodular 
simulations. 
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Parametric interlayer bonding model study 
As expected, the simulated transmural Λ1 distribution demonstrated substantial 
sliding between the fibrosa and ventricularis layers at extremely low spongiosa layer 
moduli values (Fig. 2.4). As the spongiosa modulus more closely matched that of the 
outer layers (i.e. layers becoming more bonded), the transmural variation in Λ1 became 
nearly linear. Both bending directions showed an expected shift in the neutral axis (NA) 
location towards the fibrosa layer since it was assigned a modulus stiffer than the 
ventricularis based on previous studies. From these basic simulations, we determined that 
in order for the spongiosa to exhibit measurable differences in transmural stretch from the 
fibrosa and ventricularis, μs must be less than 1 kPa. This estimated threshold is 
independent of imposed curvature. 
Transmural strain experimental results 
The M-Δκ response of AV tissue strips was observed to be slightly nonlinear in 
both bending directions (Fig. 2.5).  It should be noted that our previous work assumed a 
linear M-Δκ relationship to simplify parameter estimation [9]. The current approach was 
more accurate since the moduli were estimated directly from the M-Δκ data (Fig. 2.5), 
including accounting for the observed small non-linearity. Interestingly, as in our three-
point bending study [9], no significant directional differences were found in the overall 
flexural response (Fig. 2.5) 
However, we noted that the transmural strain measurements varied with bending 
direction. AV results revealed specimens flexed in the AC direction exhibited a 
maximum Λ1 stretch that increased from 1.016 to 1.026, with a respective increase in the 
change of curvature from 0.1 to 0.3 mm
-1
. The minimum Λ1 stretches decreased, 
indicating an increase in strain, with increasing curvature with typical values progressing 
from 0.984 to 0.969. The average neutral plane location for all specimens showed a shift 
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towards the fibrosa in the AC direction, but was not statistically significant (Table 2.2). 
The NA results indicated a shift towards the stiffer fibrosa layer.  
Refined leaflet model 
The motivation for refining the initial model was the observed differences 
between the WC and AC bending directions in the transmural Λ1 distributions (Fig. 2.6). 
That is, the M-Δκ and transmural strain responses could not be simultaneously fit in both 
bending directions (Fig. 2.6c-d).  This suggests an asymmetry in the tissue layer tensile-
compressive responses. Thus, to capture the bidirectional M-Δκ and transmural response 
of the leaflet observed in flexure, a refined FE model was created using a bimodular 
material model. Further, since the parametric interlayer bonding study and experimental 
validation indicated the leaflet tissue is a functionally bonded unit, we developed the 
following refined model by absorbing the spongiosa equally into the two outer layers, 
resulting in a bilayer model. Geometry and initial curvature of the model was matched to 
the AV experimental specimens. The following bimodular incompressible neo-Hookean 






(I1-3) - p(I3-1)         (2.4) 
which has four total moduli,  and , with the subscripts indicating the fibrosa and 
ventricularis layer and the superscripts indicating in tension (+) or compression (-), 
respectively.  
As in the first model, we conducted simulations in both flexural directions and 
simultaneously matched to the experimental data. Selected nodal positions on the edge of 
the specimen, representing tissue marker positions used in experimental configuration, 
were used to compute and equivalent change in curvature for each applied moment. The 





curvature at the center of the specimen. The experimental M-Δk data was averaged and 
fit to the FE model. The fitting procedure was carried out in a two-step process. First, the 
interrelationship of the moduli for each bending direction was determined by matching 
the location of the NA to experimental data for both directions (Table 2.2). Secondly, the 
layer moduli values were determined by fitting the M-Δκ with the experimental data 






, where n is number of experimental data points and y ̂ and y are the 
simulation and experiment derived M-Δκ relation, respectively.  It was crucial to perform 
the fitting procedure in this way to ensure both the transmural deformation and the M-Δκ 
aligned with the experimental measurements. The magnitude values reported are within 
±0.5 kPa, and the computed Λ1 through the thickness of the tissue is within the range 
experimental error (± 0.0141) of the experimental measurements (Fig. 2.6).  
An aspect of our approach is accounting for distortion of a beam of rectangular 
cross section undergoing large strains, which is a well-known effect [27]. This distortion 
causes out-of-plane warping, and was observed experimentally in the AV tissue strips. In 
the present experimental setup, out-of-plane warping (in the X3 direction) was estimated 
to affect the transmural stretch measurements by ~0.02 in the net axial stretch between 
the center of the specimen and the edge (Fig 7). Warping also affected the measured 
location of the neutral axis, making it appear almost unchanged with each bending 
direction when taken from the edge of the specimen (Figs. 7 b-c). This edge warping 
affected approximately 40% of the tissue volume (20% from each edge), leaving the 
interior 60% of the tissue largely unaffected. To account for this warping effect, we 
utilized the edge deformations to match the experimental data, as well as reported the 
predicted interior deformation responses that represent bulk tissue behavior as would 
occur in vivo.  
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The resulting simulations indicated that Λ1 in the center of the specimen 
(representing the bulk of the tissue) demonstrated significant changes in NA location with 
bending direction (Fig. 2.8). In the WC bending direction, the NA shifted towards the 
ventricularis approximately 0.35 of the normalized thickness. Interestingly, this indicates 
the whole fibrosa is under compression and the tensile load is carried entirely by the 
ventricularis (Fig. 2.8). This shift in the NA towards the ventricularis was reflected in the 
estimated moduli (Table 2.3) indicating greater tensile stiffness in the ventricularis than 
compressive stiffness in the fibrosa (a ratio of approximately 2:1). In the AC bending 
direction the NA shifts to approximately 0.79 of the normalized thickness, indicating the 
fibrosa was much stiffer under tension than compression (Fig. 2.8). Again, this shift was 
reflected in the estimated moduli values, indicating greater tensile stiffness of the fibrosa 
compared with compressive stiffness of both the fibrosa and ventricularis (ratio of 
approximately 4:1).  
Model validation 
Silicone rubber test specimens demonstrated good agreement with tensile test 
shear moduli measurements. Specifically, the model estimated 6.454± 0.168 MPa, the 
experimental flex measurement was 6.658± 0.366, and the tensile tests measuring 6.211 
± 0.225 MPa (Table 2.1). 
DISCUSSION 
Overview 
The present study investigated the interlayer micromechanics of the AV leaflet 
undergoing flexure using an integrated simulation/experimental approach.  While the 
modeling effort was rather straightforward, we noted the need for examining both the 
macro-level flexural behavior (M-Δ) and the micro-level transmural deformation, 
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integrated into a 3D beam model, to accurately capture AV leaflet layer interactions. Our 
major findings were that 1) the AV leaflet layers function in flexure as a perfectly 
bonding unit, and 2) the spongiosa layer did not have measurably different mechanical 
properties compared to the fibrosa and ventricularis. This last point was primarily 
evidenced by the smooth transmural stretch distributions (Fig. 2.4).  Thus, in the low 
strain environment, the spongiosa may be described mechanically as contiguous 
extension of the two outer layers. 
Bimodular material model for leaflet tissue in flexure 
It is important to emphasize here that a standard Neo-Hookean material, single 
layer model was only used in the first part of the study to set the basic model form and a 
range for the material model parameters. Interestingly in the refined model, a bimodular 
material model for the AV leaflet tissue in flexure was identified, similar to approaches 
used for other fibrous tissues and part of a larger sub-class of bimodular materials [28, 
29].  We also determined that both the fibrosa and ventricularis have greater stiffness in 
tension than in compression (a ratio of approximately 4:1, Table 2.3). The fibrosa was 
found to be consistently stiffer than the ventricularis, approximately 2:1 in both tension 
and compression (Table 2.3). The bimodular behavior was not entirely surprising based 
on the unique arrangement of ECM components throughout the three layers.  Moreover, 
the transmural deformation of the AV leaflet tissue indicated that the NA shifted closer to 
the ventricularis in the WC direction at all curvature levels. This implied that when the 
ventricularis was under mainly tensile loading in the circumferential direction and the 
fibrosa was fully under compression, the ventricularis provided most of the stiffness (Fig. 
2.8). When the valve flexed in the opposite direction (AC), the NA shifted closer to the 
fibrosa, leaving the entire ventricularis and one third of the fibrosa under compressive 
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loading in the circumferential direction, and the remaining two thirds of the fibrosa under 
tension, providing most of the stiffness (Fig. 2.8). Structurally, this behavior was likely 
due to the greater concentration of the comparatively stiff type I collagen within the 
fibrosa and the greater concentration of the more compliant elastin found in the 
ventricularis. Previous studies have shown that the elastin in the ventricularis forms a 
honeycomb network around the collagen fibers, allowing the fibers to stretch and return 
to their initial state [30, 31].  The collagen fibers in the fibrosa do not possess an 
extensive or organized elastin network and are bound together more tightly [32]. 
Additionally, proteoglycans intimately bind to collagen fibers and may provide 
significant reinforcement to the fibrosa in doing so, compared to the collagen-depleted 
ventricularis.  
Implications for AV micromechanical function 
Functionally, the leaflet’s ability to present low flexural stiffness during valve 
opening (WC) and high stiffness during closure (AC) is only attainable through its 
distinctive hierarchical structure in which all elements act in unison to provide seamless 
transition from the diastole to systole cycle.  The present study indicated that, contrary to 
previous hypotheses [3-7], the spongiosa did not allow the fibrosa and ventricularis layers 
to slide with respect to one another. If this did occur (i.e. when functioning as loosely 
bonded layers), each layer would have its own neutral axis (Fig. 2.4), greatly 
complicating intra-layer deformation patterns. Instead, the leaflets appear to function as a 
fully bonded unit. These findings are also consistent with our observations [1] of the 
presence of a large number of collagen fiber interconnections between the fibrosa and 
ventricularis layers. While recent work by Tseng et al. [33] shows intriguing results of 
elastin presence in the spongiosa layer, the nature of the fibrous interconnections between 
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the layers at a gross level appears to be dominated by collagenous fibers. However, the 
exact composition and structure of these interconnecting fibers remains unknown.   More 
importantly, the composition of these fibers has no effect on the findings of the current 
study, since what is important is that they exist and appear to bind the fibrosa and 
ventricularis layers.    
The question remains: what is the mechanical role, if any, of the spongiosa layer? 
In a recent study we noted that viscoelastic behavior of heart valve tissues only 
manifested themselves in the low strain region [34].  Also, other studies have 
demonstrated a functionally elastic behavior for native valvular tissues in tension [35-37].  
Yet, it can be speculated that the centrally located spongiosa layer functions to reduce 
high frequency motions of the leaflet during the opening/closing phases.  Such 
dampening-like behavior might be a mechanism to reduce hemodynamic energy loss 
during the opening and closing phases.  Current information on this aspect of valve 
function is scant, and must be the subject of future investigations.   
Limitations and the need for an integrated experimental/simulation approach 
In actual heart valves, flexure occurs during the opening/closing phases and is 
bidirectional [12, 20].  Since it is not currently possible to experimentally investigate this 
behavior directly, we chose instead to approximate this behavior with a strip model in 
circumferential bending [20].  While not accounting for bending in both directions, this is 
also the primary fiber direction and any measured behavior should approximate the native 
tissue response in vivo.  It should also be noted that Vesely et al. (1989) investigated the 
flexural behavior of native AV leaflets and found that the NA was close to the fibrosa 
surface under AC flexure, suggesting a very low compressive modulus compared to 
tensile in agreement with the present study. However, testing was performed under 
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unrealistic loading conditions, making it difficult to correlate to in vivo function.  In the 
present approach, an end-loading configuration was used, which should be more 
representative of the in vivo responses of the bulk leaflet tissue since it avoided any 
artificial contact points. We also note that the measured transmural deformation data 
must be matched with the computational model at the edge of the specimen and then 
reported from the central region in order to represent the bulk tissue behavior accurately.  
CONCLUSIONS 
In summary, the behavior of AV leaflet tissue as a composite beam was 
determined by examining the M-Δk relationship and the stretch along the edge of the 
tissue during bending. We conclude that while it has been previously speculated that 
valve layers slide with respect to one another during valve opening/closing, our evidence 
suggests that the leaflet layers function as a single bonded unit. Layers appear to be 
bonded by transverse collagen fibers that hold residual strains in place. Thus, despite a 
heterogeneous structure and differences in stress distribution throughout the layers, the 
AV leaflet deforms as a homogenous structure. Furthermore, the valve tissue in flexure 
requires a bimodular material model. Further studies are needed to investigate the leaflet 
micromechanics in activated cellular conditions that represent healthy and diseased 
physiological conditions.  
 
Specimen Model Flexure Tensile 
1 5.973 5.805 5.551 
2 6.501 6.558 6.557 
3 6.593 6.677 6.333 
4 6.749 7.591 6.403 
Average 6.454 6.658 6.211 
SEM 0.168 0.366 0.225 




 Against Curvature (AC) 
 
With Curvature (WC) 
 (mm
-1






0.1 0.5987 ± 0.0929 0.6209 
 
0.5453 ± 0.1012 
 
0.4935 
0.2 0.5903 ± 0.1022 0.5994 
 
0.5571 ± 0.1021 
 
0.5495 
0.3 0.6026 ± 0.0730 0.5835 
 
0.5629 ± 0.0315 
 
0.5670 
Table 2.2: Predicted and measured neutral axis locations. 
n=18 
Estimated Moduli Values 
(kPa) 
 









































Figure 2.1: (a) The aortic valve (b) A 1 mm x 1 mm section from the central belly 




Figure 2.2: (a) A schematic showing the orientation of the tissue strip and leaflet, and 
the location of the transmural strain measurement, (b) A free body diagram 
of tissue mounted in the testing device with a force, P, applied to its free 
end. The orientation of the X1 and X2 coordinate system specifies the X1 axis 
coincident with the circumferential direction and the X2 axis to reflect the 
thickness of the leaflet, (c) Markers used by the macro-imaging system 
shown on the edge of the tissue strip, (d) Transmural strain images obtained 
using micro camera, showing the reference and deformed tissue states.  
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Figure 2.3: Comparison of the M-Δκ data [13] with the analytical solution of the one-
term Ogden model using various α parameter values.  Note that the 
experimental data was normalized to the maximum achieved moment at a 
Δκ of 0.28 mm
-1





Figure 2.4: Transmural stretch Λ1 simulation results plotted against the normalized 
leaflet thickness. For measurable differences to occur in transmural stretch 
between the fibrosa and ventricularis, simulations indicate the spongiosa 
must possess a shear modulus less than 1 kPa. The WC bending direction 
simulation results are shown for sake of clarity, although the same 
simulation results were observed for the AC bending direction. The cuvature 
change reported is 0.2mm
-1
 since the reported results demonstrated 
independence of curvature change. 
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Figure 2.5: The M-Δκ response of a native porcine AV leaflet in the AC and WC 
directions that has been bent to a Δκ of 0.2 mm
-1 
in either direction. 
Simulations using a unimodular (dashed line) and bimodular material model 
(solid line) are superimposed over experimental data. The bimodular model 




Figure 2.6: Experimental transmural Λ1 results plotted against the normalized thickness 
for (a,c) WC and (b,d) AC samples at Δκ=0.2 mm
-1
, along with the 
corresponding unimodular (dashed line) and bimodular (solid line) 
simulation results. (a)-(b) represent strain matched in the WC direction, 
showing the resulting discrepancy in the AC fit using a unimodular model. 
Similarly,  (c)-(d) represent strain matched in the AC direction, resulting in 
a poor WC fit using the unimodular model. Although the M-Δk behavior is 
captured with unimodular model, the transmural deformation response can 




Figure 2.7: (a) Transmural Green-Lagrange strain distribution (E11) from the simulated 
flexure model demonstrating a disruption at the edges due to standard 
warping that occurs during bending. (b) A significant shift (2% stretch) in 
axial deformation is observed by plotting Λ1 vs. normalized thickness in 
both the WC and (c) AC bending directions. It is important to note the 
associated shift in the neutral access location when observing deformation at 
the edge or in the unaffected central region of the tissue. 
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Figure 2.8: A schematic summarizing the changes in NA location experienced by the 
bulk tissue for both bending directions. In the WC bending direction, the 
NA shift towards the ventricularis approximately 0.35 of the normalized 
thickness, demonstrating the whole fibrosa under compression (-) and the 
majority of the ventricularis under tension (+). In the AC bending direction 
the NA shifts to approximately 0.79 of the normalized thickness. These 
results indicate that both the ventricularis and fibrosa are much stiffer under 
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CHAPTER 3: IN SITU CONTRACTILE BEHAVIOR OF THE 
AORTIC VALVE INTERSTITIAL CELL 
Preface 
As a first step in understanding AVIC behavior in the normal AV, the non-viable 
tissue model developed in SA 1 (Chapter 2) was extended to formulate a macro-micro 
FE model to simulate mechanical behavior of AVICs under activation. As a brief 
overview, the developed macro (tissue) level model presented in this chapter captures the 
bidirectional flexural response of AV intact layers at different activation states from 
previous studies [1].  At the micro-level tissue AVIC size, shape, distribution and 
orientation were quantified from histological data from all layers. A representative 
volumetric element (RVE) was then optimized statistically for each layer to represent the 
native 3D structure. AVIC stiffness, contraction and connectivity were built into the 
micro-model framework as variable parameters. Displacements at the RVE boundaries in 
the macro-model were then applied as boundary conditions to the micro model RVE. For 
each parametric iteration, resulting stress was averaged over the entire RVE and 
compared to the stress of the homogenized RVE in the macro-model until an acceptable 
fit was met, arriving at a parameter estimation for each AVIC activation state. The 
objective of this study was to create a macro-micro model to use in conjunction with new 
and existing tissue level bending data to probe the effects of AVIC stiffness, AVIC 
contraction and AVIC-ECM connectivity on the tissue level response during flexure.  As 
mentioned prior, the numerical-experimental methodology presented in this chapter can 
be paired with biomechanical experimental testing to probe the activation state of the 
AVIC in response to different activation stimuli. Predicting the physical state of AVICs 
in-situ provides a significant advantage from ex-situ measurements in that AVICs remain 
in the native microenvironment, maintaining essential AVIC-ECM coupling. 
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INTRODUCTION 
As discussed previously, the aortic valve (AV) is comprised of three layers 
(fibrosa, spongiosa, ventricularis), the division of these layers is characterized by distinct 
variations of collagen, glycosaminoglycan (GAG), and elastin. Each tissue layer is 
maintained by aortic valve interstitial cells (AVICs), which are highly contractile and 
known to possess plastic phenotypes.  During normal valve function, AVICs exhibit a 
heterogeneous phenotype, with characteristics reminiscent of both fibroblasts and smooth 
muscle cells. With the onset of disease, AVICs transition into a highly contractile 
phenotype and are loosely referred to as the commonly known myofibroblast. Calcified 
valves have been shown to possess a large population of myofibroblastic-like cells [2] 
that are characterized by an upregulation of alpha smooth muscle actin (αSMA) and an 
associated increase in contractile behavior. AVICs are often referred to as “activated” as 
they transition to the myofibroblast phenotype during growth and disease and contribute 
to altered extracellular matrix (ECM) composition seen in diseased valves [3]. 
The key role the microenvironment plays during the progression of disease is 
highlighted by the variability of disease manifestation throughout the layers. Severely 
stenotic aortic valves exhibit calcified nodules almost exclusively on the fibrosa side, the 
ventricularis otherwise appears healthy [4]. To date, there has been little characterization 
of the surrounding AVIC microenvironment, however, its role in shaping AVIC behavior 
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is clearly demonstrated by numerous studies [5-11]. AVICs are physically coupled with 
the surrounding ECM, via α2β1 integrins, a major collagen-binding protein. The necessity 
of maintaining VIC-ECM coupling in actin-mediated VIC force generation has been 
demonstrated in mitral valve leaflet tissue [12] and is hypothesized to be as essential in 
the aortic valve.  
AVIC culture in 3D synthetic and natural gels have provided valuable insight and 
aided in characterization of VIC healthy and diseased phenotypes [13-15]. The advantage 
to these simple systems is their tunability, allowing tailoring for each study to answer 
specific biological questions. However, gel systems are severely limited in that they lack 
the complexity of native tissue. In particular, Butcher et al. [16] found that the VIC 
expression of αSMA in 3D collagen gel culture was significantly reduced compared to 
expression on 2D substrates. This further highlights the role of matrix interaction in 
modulating AVIC phenotype. Similarly, as mentioned in Chapter 1, our research group 
has demonstrated that measuring mechanical stiffness of nonadherant VICs using 
micropipette aspiration [17] and monolayer (2D) cultured VICs using atomic force 
microscopy [18] provide similar trends when comparing pulmonary VICs (PVICs) vs. 
AVICs, yet with stark differences in magnitude (approximately 10-fold). This further 
implies the significance of the VIC microenvironment in dictating phenotypic activity.  
Given the overwhelming body of evidence that VIC-ECM connectivity plays a 
crucial role in VIC biomechanical state, the need for assessing VIC behavior in its native 
environment seems obvious, yet unattainable using existing experimental methodologies. 
Existing methods of measuring cell mechanics are all destructive in nature: micropipette 
aspiration (MA), atomic force microscopy (AFM), and magnetocytometry (MCT) for 
example. To assess the underlying mechanical behavior of cells in dense connective 
tissues a computational approach is necessary.  
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Continuum based constitutive models are limited to macroscopic tissue behavior, 
and do not have the ability to capture mechanical behavior at the lower microscale 
making them insufficient for studying structure-functional relationships in hierarchical 
tissue structures such as the AV. Like heart valves, bone, cartilage and tendons are all 
hierarchical structures. Therefore, developing computational models for these dense 
connective tissues involves spanning multiple length-scales using what are loosely 
termed “multi-scale models”. Multiscale modeling allows the integration of 
microstructural level details into a modeling framework, thereby providing a more 
realistic representation of tissue complexity and relating the underlying structure 
mechanics to the overall tissue mechanics. Variations of multi-scale models have been 
poised for bone [19-22], cartilage [23-26], tendons [27, 28], heart valves [29-31], and 
generalized dense connective tissue [32-34]. However, many of these examples do not 
include the contributions of cells, only incorporating ECM structural details. The few 
models that do include cells, such as the work by Lai et al. [32], only consider the passive 
contribution, ignoring any contractile capabilities. A further limitation to this work is that 
it is built using experiments observing cell behavior in 3D collagen gels, which greatly 
underestimates the complexity of native tissue as mentioned previously. 
Traditional multi-scale methodology 
Multiscale modeling approaches in mechanics aim to link the macro and micro 
scales of materials. Homogenization is the process of obtaining a macroscopic-level 
stress-strain response from a material’s underlying microstructure. The macro-scale 
problem is discretized using FE absent of any assumptions regarding the material 
constitutive response. Instead, at every material point where the constitutive response is 
needed, the macro deformation gradient tensor FM (Fig. 3.1) is calculated and used to 
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formulate and solve a micro-scale boundary value problem (BVP) imposed on a 
representative volumetric element or RVE. The micro-scale problem is solved to find the 
microscopic stress distribution in the entire micro-scale domain. Using the computational 
homogenization method, the macroscale stress tensor, PM is calculated from the stress 
distribution in the micro-scale problem and fed back to the macro-scale. Consequently, 
the macroscopic stress tensor is calculated at every material point by solving the 
corresponding RVE problem. The RVE size can be identified one of two ways, first, it 
can be based on the statistical nature of the material microstructure in that it must be the 
smallest material volume statistically representative of the microstructure [35]. Second, 
the RVE can be defined as the smallest volume of the heterogeneous material whose 
behavior represents accurately the actual macroscopic behavior. The homogenization 
theory facilitates carrying out microstructural and continuum analyses separately and then 
combing them systematically in this manner. This schematic introduced by Kouznetsova 
et al. [36] is introduced in Fig. 3.1. 
Limitation for biological materials 
When applying a traditional macro-micro homogenization approach to the context 
of the AV, the sizing requirement between scales must be revisited. The basic scaling 
requirement for the macro-micro approach described above is for the microscopic length 
scale to be significantly smaller than the characteristic size of the macroscopic sample. 
This implies that the average size of the AVICs, the underlying constituents, must be far 
smaller than the thickness of the individual valve layers if we are to treat each layer as a 
separate material model with its own individual RVE. The AV has an average thickness 
of approximately 500 microns, with the thinner ventricularis and spongiosa layers 
averaging around 30% of this volume (~150 microns), and AVIC sizes have been 
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reported to be approximately 15 microns. When sizing the RVE appropriately in this 
context, the upper bound would be 150 microns (macro), with a lower bound of 15 
microns (micro). This represents a scale separation of 10:1 at best between the RVE and 
the underlying constituents if the RVE were to be at the upper bound of size. This 
similarity in scale simply does not satisfy these requirements for a traditional multi-scale 
framework. 
Furthermore, the multi-scale approach is also dependent upon known behavior at 
the micro-scale. For non-biological materials this approach works well, however for 
living tissues, microstructures are often non-uniform and are difficult to study without 
significantly altering the tissue during preparation or the process itself. Therefore, given 
the presented scale separation challenges, as well as the poorly characterized underlying 
microstructure, utilizing a traditional multi-scale framework is not feasible in this 
context. To accomplish a reasonable approach for estimating changes in underlying 
AVIC behavior in response to various stimuli, a variation of the traditional macro-micro 
mapping methodology is introduced in detail in this chapter and summarized in Fig. 3.2. 
Briefly, unlike traditional multi-scale methods, a constitutive material model at the macro 
level is used to represent AV observed bending behavior. Experimental data acquired 
from our laboratory from non-viable [37] and activated viable AV tissue under flexure 
[1] enabled the development of a tissue-level model with an accurate representation of 
observed layer differences. To estimate the contribution of the underlying AVIC changes 
in stiffness and contraction to observed tissue changes under flexure [1], a second FE 
model was developed that is microanatomically representative of what we currently 
understand of AV microstructure. To inversely compute AVIC changes from tissue level 
flexure measurements, AVIC material properties were varied parametrically, and 
optimized by minimizing the difference between the volumetric averaged homogenized 
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stress of the RVE between scales. To summarize, the following two objectives will be 
addressed in this chapter by the development of a macro-micro FE model: 
1) Identify a unique constitutive model that captures the bidirectionality of 
the AV leaflet flexure response under varying contractile states based on 
experimental data (macro-model) 
2) Map the measured layer specific tissue response down to the micro cell 
(AVIC) level and inversely estimate contributions of AVIC stiffness, 
contraction and ECM connectivity to the macro tissue-level response 
(micro-model) 
METHODS 
Flexural tissue testing 
Examining the leaflet under bending deformation is ideal for several reasons: it is 
physiologically relevant representing the opening and closing of the leaflets, it is 
exquisitely sensitive to low force measurements and most importantly it allows us to 
observe the layer effects of the leaflet which have been shown to be a key contributor to 
bending behavior. Experimental data acquired from [1] were used to develop the macro 
component of the macro-micro model. Briefly as described in [1], viable strips of porcine 
tissue from the belly region of the AV were tested under 3-point bending using a custom 
flexure testing device [38]. Leaflets were bent with the natural leaflet curvature (WC) and 
against (AC) the natural leaflet curvature under three activation levels: inactive 
(thapsigargin), normal (norm: 5Mm KCl) and hypertensive (hyper: 90Mm KCl). Each 
specimen was first tested in Dulbecco’s Modified Eagle Medium (DMEM) with high 
glucose supplemented with 5 mM KCl. Testing media was then changed to DMEM with 
90mM KCl and specimens were allowed to incubate for 3 minutes prior to testing a 
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second time in both WC and AC bending directions using the same procedure. A separate 
group of specimens was incubated overnight in 10µm thapsigargin and tested using the 
same procedure.  
The mean strip thickness, t, was calculated from averaged measurements over the 
strip’s entire length. Between 8 and 12 graphite markers were attached to the cut surface 
nearest the coapting edge using cyanoacrylate. The specimen was held upright with two 
sleeves, which were supported by stationary posts while the bending bar was applied to 
the center of the tissue. In order to determine the deflection of the bending bar during 
testing, a reference rod was attached to the stage that was displaced equivalently with the 
bending bar base. Therefore, with all the aforementioned components, it was possible to 
record while testing, the stationary posts, bending bar, reference rod, and specimen 
markers. As the specimen was deflected, the image was recorded on a VHS tape which 
was used for data analysis after testing. The marker, post, and bending bar positions were 
entered into a custom Matlab program that calculated the resulting moment, M 
(mN*mm), about the right post from the centrally applied load, P (mN); and the change-
in- curvature, Δκ (mm
-1
), of the tissue at small time increments during the loading. The 
local radius of curvature was determined from the parabolic curve fit to the markers. The 
applied moment M versus the measured change in curvature Δκ is related by the 
Bernoulli-Euler moment-curvature equation: 
 
𝑀 = 𝐸𝑒𝑓𝑓𝐼∆𝜅         (3.1) 
 
Where 𝐸𝑒𝑓𝑓𝐼, or flexural rigidity corresponds to the slope of the measured M- Δκ 






          (3.2) 
 
Where t and w refer to the thickness and width of the sample respectively. The average 
bending response of the tissue was taken for each bending direction and each activation 
state. Outliers were determined as specimens lying outside of 2.5 times the standard 
deviation and not included in the final average in Fig. 3.3. 
The effective modulus, Eeff, was determined from a linear regression of the M vs. 
Δκ plots at the maximum Δκ reached. A one-way Repeated Measures Analysis of 
Variance was performed on the WC group between normal and hypertensive and the AC 
group also between normal and hypertensive since the same samples were treated with 
both conditions. All statistical analyses were performed with SigmaPlot (San Jose, CA, 
USA). All additional pairwise multiple comparison procedures used a one-tailed t-test 
with an overall significance level of 0.05. 
Macro-model 
For clarity, a summary of nomenclature used in the macro and micro FE models 
as well as general acronyms is provided in Table. 3.1. 
Formulation 
The macro and micro FE models were created in the framework of ABAQUS 
version 6.14 (Dassault Systemes, Johnston, RI, USA). All FE simulations were run on a 
Linux machine equipped with 16 core Intel Xeon E5-2650 CPU. 
In Chapter 2 it was demonstrated that modeling the AV leaflet tissue as a 
bilayered bonded unit under bending deformation was accurate in capturing the overall 
tissue stiffness as well as the underlying strain [39]. Accordingly, the macro model tissue 
strip was modeled in 3D as a bilayered and biomodular neo-Hookean isotropic nearly 
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 represents the shear modulus of the Macro material for a given layer (F-
fibrosa and V-ventricularis) under tensile load (+) or compressive load (-). 𝐼1 and 𝐼3 are 
the first and third invariant of the left Cauchy-Green deformation tensor C=F
T
F, 
respectively, and p is the Lagrange multiplier to enforce incompressibility. It is important 
to point out the macro subscript, which indicates a material parameter specific to the 
macro model, not to be confused with the subsequent Micro model. This model is used at 
the continuum level FE simulations to accurately represent the bending behavior of AV 
tissue strips. 
Boundary conditions 
The boundary conditions used in the FE simulation consisted of the left edge of 
the specimen treated as a pin constraint and the right edge subjected to incremental 
controlled displacement (Fig. 3.4). End-loading was used in place of 3-point loading due 
to the necessity of collecting detailed information from representative volumetric 
elements (RVEs) from the center of the specimen, at the point of greatest moment and 
curvature. End-loading constraints avoided the effects of point loads in the vicinity of the 
RVEs and facilitated faster computational time. Practically speaking, future flexural 
testing of AV tissue will also exhibit end-loading as it allows for acquisition of 
transmural strain at the center of the specimen. The value of this additional information is 
discussed in detail in [39]. 
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Mesh 
The macro mesh represented the native geometry of the experimentally tested AV 
leaflet strips. A bilayered beam slightly bent (0.01 mm
-1
 curvature) with averaged length 
and thickness of the experimental samples (15mm in length x 4mm width x 0.462mm 
thickness). The fibrosa (F) layer was modeled as 60% of the beam thickness and the 
ventricularis (V) the remaining 40% as previously reported based on native tissue 
measurements [40] and the determination to model the tissue as bilayered as opposed to 
trilayered [39]. The finalized mesh contained 12,200 isoparametric second order hybrid 
brick elements. A single element of the macro model was representative of the micro 
RVE in each of the layers (𝑅𝑉𝐸𝑙𝑎𝑦𝑒𝑟). 
Estimating tissue parameters 
Nodal displacements and elemental and nodal stress and strain fields were output 
from the FE simulations. Parametric simulations were carried out to estimate the shear 
modulus of the bulk tissue for each layer (F and V) (state𝜇𝑀𝑎𝑐𝑟𝑜
𝑙𝑎𝑦𝑒𝑟±
) at each activation state 
(inactive, norm and hyper). Using displacement of nodal “markers” the M-Δκ response 
was computed for each parametric iteration and a MSE was computed against the 
experimental data M-Δκ response. A custom script was written to minimize the MSE 
using the scipy.optimize Python package and is summarized in Fig. 3.5. The location of 
the neutral axis was determined by plotting the stretch tensor component along the length 
of the beam (U11) against the thickness of the tissue beginning with the ventricularis side 
(0.0) through to the fibrosa (1.0). The depth of the tissue that coincided with the U11 value 
of unity was the corresponding location of the neutral axis.  
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Macro RVE averaged stress 
We assume the macroscopic stress at a material point is equal to the averaged 







∫ ?̃?(𝑥)𝑑𝑉       (3.4) 
The average stress of the macro RVE (Eq. 3.3) was computed using a custom Python 
script, extracting the FE estimated stress at all 27 nodes and numerically integrating using 
a 3-point Gauss quadrature in three dimensions. 
Micro-model 
RVE geometry and mesh 
Drugan and Willis (1996) identified that to determine the appropriate size of an 
RVE it must be the smallest material volume that statistically represents the 
microstructure [35]. The density and spatial distribution of AVICs within the micro mesh 
were defined using data from [40] and [41]. The detailed data was used to establish an 
appropriate size range through the use of statistical dimensional analysis [40, 41]. AVICs 
were modeled as ellipsoid inclusions 14.16 microns along their long axis, and 7.49 
microns along the short axes (Fig. 3.6b). A density of 270 million AVICs per mL was 
maintained in all RVE sizes. The orientation of the AVICs had a preferred nuclear 
direction along the circumferential direction in the circumferential-radial plane, with 
orientation angles normally distributed around 9.7 and 5.3 respectively (Fig. 3.6c). 
Second, using the study by [42] to determine the maximum AVIC contractile force that 
may occur under uniaxial isometric conditions, in combination with the AV experimental 
bending data to determine the maximum strain any RVE would experience, a “worst case 
scenario” condition was developed. A maximum contractile force of 100nN per cell 
 95 
(method of imposing contractile force described in detail in subsequent section) was 
imposed on the AVIC inclusions embedded within the mesh and the RVE was subjected 
to 8% uniaxial extension. The resulting volumetric stress was then computed. The size of 
the RVE was increased from 20 microns to 120 microns to examine the stress variation 
within the RVE as a result of increasing cube length (Fig. 3.7). The averaged stress was 
taken (Eq. 3.4) and the standard deviation of each component of the averaged tensor was 
determined from the stress at each RVE node described in (Eq. 3.5). Lastly, a scalar 
index (Frobenius norm Eq. 3.6) was used and minimized to identify the appropriate RVE 
size without compromising computational time. This was determined as the appropriate 





∑ (?̃?(?̂?) − ?̅?𝑅𝑉𝐸)
2𝑁
𝑖=1      (3.5) 
 




𝑖=1       (3.6) 
 
The final RVE size was determined to be 80 μm
3 
after the stress variation stabilized at a 
constant 0.2% deviation from the mean stress of all nodes (Fig. 3.7). The final RVE 
volume contained 138 AVIC inclusions and 210,708 first order hybrid tetrahedron 
elements. The volume fraction of AVICs is approximately 10% which corresponds to the 
established 270 million AVICs/mL density. 
Formulation 
An overview of the micro-model framework is provided in Fig. 3.8. The same 
bilayered and biomodular nearly incompressible neo-Hookean material was used to 
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model the ECM of the micro model. The material model used for the AVIC ellipsoidal 
inclusions was also a neo-Hookean nearly incompressible material, with the addition of 
isometric thermal expansion [43]. The addition of thermal expansion was used as a means 
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Where 𝐷1 is a material constant defined by 
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, κ being the bulk modulus of the material 
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𝐽𝑡ℎ = (1 + 𝑡ℎ)3        (3.9) 
 
Where 𝑡ℎ is the thermal expansion strain that is obtained from the temperature (T) and 
the isotropic temperature dependent thermal expansion coefficient (𝛼) here: 
𝑡ℎ = 𝛼ΔT         (3.10) 
For all parametric simulations of the micro model, ΔT was kept constant and 𝛼 values 
were later correlated to AVIC forces as described in detail below.  
Layer-specific connectivity 
Layer-specific microstructural ECM composition was not incorporated into the 
material model of the ECM, however AVIC-ECM connectivity differences throughout 
the layers were represented by the addition of a thin interface boundary around each 
AVIC (0.650µm). The modulus of this interfacial layer is assumed to be equivalent to the 
modulus of the AVIC, 𝜇𝐴𝑉𝐼𝐶
𝐹,𝑉±




which encompasses a range β𝐴𝑉𝐼𝐶
𝐹,𝑉± ∈[0,1]. When β=1, the AVIC is continuously bounded 
to the surrounding material (ECM) and as β approaches zero, it becomes less connected 
(Fig. 3.9). 
Recent work in our group mentioned in Chapter 1, discovered that in the mitral 
valve, MVICs are phenotypically similar and differences in MVIC deformation 
throughout the layers is a result of varying mechanical stimuli due to changes in ECM 
microstructure and not necessarily MVIC behavior [44]. In the current model, this 
assumption was carried over to the micro model framework. The level of contractile force 
(α) exerted by the AVIC on the surrounding matrix was held constant for each activation 
state amongst all the layers. Instead, the 𝛽 connectivity parameter was introduced to 
emulate AVIC-ECM layer differences. This enables the macro-micro model to capture 
the bidirectional behavior discovered experimentally and in particular the stark 
differences between the AC and WC response to hypertensive conditions.  
Macro-micro coupling 
Micro-model boundary conditions 
Isoparametric interpolation using the displacement at the nodes of a single macro 
hexahedral element (80 μm
3
) was used to compute the displacement on the 6,144 surface 
nodes of the refined micro mesh.  This procedure was done for the fibrosa layer RVE 
(𝑅𝑉𝐸𝐹) as well as the ventricularis layer RVE (𝑅𝑉𝐸𝑉). Boundary conditions for each 
layer’s RVE were computed using a custom Python script and an ABAQUS input file for 
the micro-model FE simulation was generated. 
Macro-micro matching method 
The volumetric averaged stress is computed for the micro model RVE 
(state𝜎𝑀𝑖𝑐𝑟𝑜
𝑙𝑎𝑦𝑒𝑟±
) using the same method described for the macro model RVE (Eq. 3.4).  The 
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where 𝜎′ is the deviatoric stress and the difference between the two homogenized von 




𝑉𝑀            (3.12) 
 
‖Δ‖ = √Δ: Δ⌉
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        (3.13) 
Systematic error check 
To determine the systemic error of using this macro-micro mapping approach, 
two internal validations were performed. First, a homogenized macro material was 
mapped down to a homogenized micro material mesh using identical material parameters 
from the baseline inactive (thapsigargin treatment) state. This was done for both layer’s 
RVEs under tension and compression and a maximum error was found to be 1.48% 
between the macro and micro homogenized stress amongst all cases. Second, to ensure 
that modeling the macro RVE as a single 27-node hexahedral element was sufficient, a 
mesh refinement study was performed using 1, 27 and 64 element RVEs. The error 
between the macro and micro volume change was examined to ensure the appropriate 
level of incompressibility was maintained in both models. The error was sufficiently low 
with a single RVE (0.01%) and not much improvement was gained with 64 RVEs (0.005 
%). To keep computational costs low, a single RVE was used in all simulations reported. 
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Preliminary micro model parametric studies 
Several preliminary steps were taken prior to running parameter estimation 
studies to back out changes in AVIC stiffness, contractility and connectivity for each of 
the activation states. First, the baseline modulus of the ECM in the micro model (𝜇𝐸𝐶𝑀
𝐹,𝑉±
 ) 
and the basal shear modulus of the AVIC 𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙, were computed using the following 
information from the inactive (thapsigargin) state (Eq. 3.14). For clarity purposes, all 
examples provided, including Eq. 3.14, will be for the fibrosa RVE (𝑅𝑉𝐸𝐹) under tensile 
loading. The same procedure was executed for the fibrosa under compression, and the 
ventricularis under tension and compression and are reported in the results. 
inactive𝜇𝑀𝑎𝑐𝑟𝑜
𝐹+ = 𝜇𝐸𝐶𝑀
𝐹+  Φ𝐸𝐶𝑀 + 𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙Φ𝐴𝑉𝐼𝐶     (3.14) 
Where Φ𝐸𝐶𝑀and Φ𝐴𝑉𝐼𝐶 are the mass fractions of the ECM and AVICs respectively. The 
value of 𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙 represents passive AVIC stiffness. A physically realistic range of AVIC 
stiffness values for the basal AVIC stiffness are identified as ranging from micropipette 
aspiration estimates of 0.15 kPa, to 50 kPa. This is equivalent to a linearized elastic 
modulus (E) range of 0.45kPa to 55 kPa. 
 For each assigned value for 𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙, a parametric study of AVIC contractility 
(𝛼𝐴𝑉𝐼𝐶
𝐹+ ) was performed. Since inactive𝜇𝑀𝑎𝑐𝑟𝑜
𝐹+  represents the bulk moduli estimated from the 
macro-model, for every assigned 𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙 value, 𝜇𝐸𝐶𝑀
𝐹+  can be solved for (Eq. 3.14) to 
obtain the baseline shear modulus of the ECM in the micro-model. After 𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙 is 
assigned and 𝜇𝐸𝐶𝑀
𝐹+ is solved for accordingly, these parameters remain constant while the 
AVIC contractility is varied (𝛼𝐴𝑉𝐼𝐶
𝐹+ ). For each assigned basal AVIC stiffness 𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙, the 
necessary contractility parameters to achieve the normal and hypertensive stress states 
determined by the macro model, were determined. 
A key part of these preliminary steps was determining the appropriate value for 
𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙, moving forward by validating the initial parametric study results (varying 𝛼𝐴𝑉𝐼𝐶
𝐹+ ). 
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against an independent data source under separate loading conditions [42]. Briefly, 
porcine AV leaflets were cut into circumferential strips from the belly region of the AV 
(same region as the flexure study presented here). The strips were oriented 
circumferentially, set up in isolated organ baths with on end attached to a strain gauge 
force transducer and the other end fixed to a steel rod. Tissues were allowed to stabilize 
in Krebs solution (approximately 2.7Mm KCl) for 10 minutes before being loaded with a 
pre-tension of 3mN. After stabilizing to a baseline force (not reported) over a period of 
40 minutes, the viable tissue was tested in 90Mm KCl and the contractile response was 
measured. This study provided an indication of the collective contractile force of the 
AVICs to achieve a hypertensive state (90mM KCl) from a normal baseline (5mM) (Fig. 
3.9a). This experiment was simulated using the developed micro-model, constraining the 
two faces of the RVE perpendicular to the circumferential direction, varying the 
contractility of the AVICs using the α term and computing the resulting force on the faces 
(Fig. 3.9b). This resulting axial force computed by the simulation was then directly 
compared to the force measured directly by the experiment, accounting for changes in 
size of the true vs. simulated tissue strips. The change in the α term (Δα) needed in the 
model to achieve the change in force measured from normal (5mM KCl) to hyper 
(90mM) activation states was determined to be approximately 6E-5 (1/K).  
Lastly, understanding that it should take a Δα of approximately 6E-5 (1/K) to 
achieve hyper stress levels from the normal state, the estimated Δα values for each of the 
assigned 𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙 values was evaluated. Results revealed that a basal AVIC modulus of 
18kPa was appropriate given that it takes a Δα of approximately 6.98E-5 1/K to reach the 
hyper state from the normal state (Fig. 3.10). Additionally, a modulus of 18kPa aligns 
with previous AFM data measurements of AVICs [18]. For these reasons, a 𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙 of 
18kPa was established moving forward. 
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Micro model parametric studies: estimating AVIC stiffness, contractility and 
connectivity 
After the appropriate ranges of parameter values were chosen for μAVIC
F+  and  
αAVIC
F+ , a parametric simulation was run using the micro FE model with the computed 
macro model boundary conditions. Resulting homogenized stress of the micro RVE 
state𝜎𝑀𝑖𝑐𝑟𝑜
𝐹+  was computed at each perturbation using Eq. 3.4 and compared to the macro 
RVE homogenized stress (state𝜎𝑀𝑎𝑐𝑟𝑜
𝐹+ ) as described in Eqs. 3.11-3.13 for each activation 
state. 
Validation of macro-micro methodology 
The developed model was validated in two ways. First, to validate the custom FE 
code and macro-micro mapping procedure, the model was run against experimental 
results using hydrogel tissue phantoms with embedded inclusions of known stiffness. 
Polyacrylamide (PAM) gel strips similar in size to the AV tissue strips were created with 
polymethylmethacrylate (PMMA) microspheres inclusions with diameters between 20-
27µm. This represents an exaggerated stiffness relative to the surrounding matrix using 
particles of the same scale as AVICs. PAM gels were cast with reagents from Bio-Rad 
(Hercules, CA) following manufacturer instructions. Briefly, the appropriate 
concentration of acrylamide/bis-acrylamide solution was mixed in distilled H2O, 10% 
sodium dodecyl sulfate and 1.5M Tris HCL buffer to obtain a final acrylamide 
concentration of 20%. PMMA particles were added to the gel at a 10% volume fraction to 
match that of the AVICs in the micro model. Polymerization was initiated through the 
addition of freshly prepared 10% ammonium persulfate and tetramethylenediamine 
(TEMED) was used as a catalyst. The gels were left to polymerize through free radical 
polymerization of the acrylamide monomers and the bis-acrylamide cross-linker for 1 
hour at room temperature. Polymerized gels were cut using a mold to be 1mm thick, 
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4mm wide and approximately 15mm in length prior to testing and mounted on a custom 
end-loading flexural testing apparatus described in detail in [39]. The M vs. Δκ bending 
response was measured and parameters were estimated from the macro FE model by 
fitting against the acquired data. The boundary conditions extracted from the macro 
model were then applied to a modified micro-model using 20 µm spherical inclusions and 
using the methodology described previously, the stiffness of the inclusions was estimated 
through parametric perturbations until the homogenized stress was matched to that of the 
macro-model. 
Second, the estimated values for AVIC stiffness and contraction using the macro-
micro model were validated against the independent data source under separate loading 
conditions as described in detail previously. This study provided an indication of the 
collective contractile force of the AVICs to achieve a hypertensive state (90mM KCl) 
from a normal baseline (5mM), of approximately 1.41µN per AVIC.  
Immunofluorescence 
To qualitatively investigate layer differences in AVIC connectivity to the 
surrounding ECM, F-actin networks were stained in native AV tissue. Fresh porcine 
aortic valves were obtained from the local abattoir (Harvest House Farms, Johnson City, 
TX) and transported in HypoThermosol FRS (StemCell Technologies, Vancouver, BC) 
on ice. Within 2 hours of sacrifice, fresh pieces of valve tissue were cut into 5mm x 7mm 
(average thickness of 400 µm) rectangular sections, fixed in 2% paraformaldehyde 
(Electron Microscopy Sciences, Hatfield, PA) for 30 minutes. Tissue was processed 
through a sucrose gradient (10%, 20%, 30%) for 30 minutes each at 4°C. over dry ice in 
optimum cutting temperature embedding compound (Tissue-Tek, Sakura Finetek, 
Torrance, CA) and shipped to Histoserv (Germantown, MD) where they were 
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cryosectioned into 5 micron thick sections (transmural) and kept frozen at -80°C until 
staining. Slides were removed from -80°C, brought to room temperature and rehydrated 
with a series of PBS washes. Sections were treated with 0.1% Triton X-100 in PBS for 5 
minutes at room temperature to permeabilize cells. Sections were washed and blocked 
from non-specific staining between primary antibodies and tissue by incubating in 
blocking buffer of 10% goat serum in PBS for 45 minutes. Slides were rinsed and 
surrounded with a hydrophobic barrier prior to incubating with TRITC-conjugated 
Phalloidin (1:100, Millipore, Billerica, MA), a high-affinity filamentous actin (F-actin) 
probe, for 1 hour at room temperature. AVICs nuclei were stained with DAPI (Life 
Technologies, Carlsbad, CA) for 5 minutes prior to mounting with ProLong Diamond 
Antifade mountant (ThermoFisher Scientific). Fluorescent images were taken with a 
fluorescent microscope using standard TRITC and DAPI filters (Zeiss Axiovert 200M, 
Zeiss, Germany). 
RESULTS 
Effective moduli values and fold increase 
Statistics revealed a significant difference (p=0.024) between the measured 
effective modulus at the normal state (5mM KCl) compared to the hyper state (90mM 
KCl) when bending in the AC direction (Fig. 3.12). However, no statistical difference 
(p=0.839) was found between the normal and hyper modulus values for the WC bending 
direction. This knowledge prompted the hypothesis that additional increases in tissue 
stiffness from 5mM to 90mM KCl could be attributed primarily to the fibrosa layer. 
Parameter estimation results discussed below did in fact reveal that truly unique 
parameter sets matching tissue stiffness in both bending directions for activation states 
were only attainable by increasing the tensile shear modulus in the fibrosa layer. 
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Increasing the shear modulus of the fibrosa layer alone caused the neutral axis in the AC 
bending direction to shift from 0.75 of the normalized thickness to 0.87 when stimulated 
with 90mM KCl (Table 3.2). Contrasting with the WC bending direction, where upon an 
initial shift from the inactive state to the 5mM normal state (0.36 to 0.28) towards the 
ventricularis, no further shift occurs with the addition of 90mM KCl. 
Parameter estimation of the macro-model 
Using the established moduli relationships discovered in [39], the thapsigargin or 
“inactive” tissue state moduli were estimated by fitting the FE simulations to the 
experimental data (Fig. 3.13). The reported parameters (Table 3.2) differed slightly in 
magnitude from the previously reported estimates, however this was anticipated due to 
variability of tissue samples and an independent protocol for the study. With the addition 
of 5mM KCl, the fibrosa layer stiffens 7.25-fold from the inactive state in contrast with 
the ventricularis which stiffened approximately 3.24-fold from the inactive state. With 
the addition of 90mM KCl, the model revealed an additional 1.5-fold increase in stiffness 
from the normal state. In contrast, the ventricularis revealed no further increase in 
stiffness from the normal state. As mentioned above, the increasing stiffness of the 
fibrosa under tensile loading corresponds with an expected shift in the neutral axis (10% 
shift towards the fibrosa). Similarly, there was a slightly less 8% shift towards the 
ventricularis that accompanied the stiffness increase from the inactive to normal/hyper 
activation states.  
Macro RVE averaged stress 
Extracted nodal and elemental values for displacement and stress from the 
simulation were taken at 0.15mm
-1 
change in curvature and provided to the micro-model 
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study for AVIC property estimation studies. The homogenized von Mises stresses are 
reported in Table 3.3. All values are reported within ±0.02 kPa. 
Micro model estimates of AVIC stiffness, contractility and connectivity 
The micro-model parametric studies were completed in two steps. First, 
parametric studies of stiffness and contractility for the fibrosa and ventricularis under 
tension were carried out while maintaining a constant connectivity parameter of 
𝛽𝐴𝑉𝐼𝐶
𝑙𝑎𝑦𝑒𝑟+
=1. Therefore, initially all AVICs were assumed to be continuously bound to the 
surrounding matrix. Second, using a priori results from the first study, the connectivity 
parameter was decreased for AVICs (𝛽𝐴𝑉𝐼𝐶
𝑙𝑎𝑦𝑒𝑟+
<1) in the ventricularis layer using a 
uniform contractile force and stiffness. This second parametric study allowed for the 
estimation of relevant layer differences in AVIC-ECM connectivity. Since the macro-
model indicated negligible contribution from the layers under compression, parametric 
studies are only reported for the layers under tension. 
Fibrosa and ventricularis under tension: uniform connectivity 
The first micro parametric studies of AVIC stiffness (𝜇𝐴𝑉𝐼𝐶
𝐹+,𝑉+
 ) revealed little to no 
changes in RVE homogenized stress with no contractility implemented in the model 
(𝛼𝐴𝑉𝐼𝐶
𝐹+,𝑉+
=0). Even a substantial increase in AVIC modulus to 50kPa was incapable of 
achieving normal stress states.  However, parametric studies of AVIC contractility 
(𝛼𝐴𝑉𝐼𝐶
𝐹+,𝑉+
) revealed a substantial measured change in stress of the RVE (Fig. 3.14a-b). It 
took an approximate  𝛼𝐴𝑉𝐼𝐶
𝐹+  value of 25E-5 (1/K), to achieve normal activation levels and 
an additional 7E-5 (1/K) to achieve hyper activation states (Fig. 3.14a). The trends 
observed for the ventricularis under tension were the same, requiring a lower contractile 
force parameter (𝛼𝐴𝑉𝐼𝐶
𝑉+ ) of 23E-5 (1/K) to achieve the macro-level contractile state (Fig. 




 ), contraction (𝛼𝐴𝑉𝐼𝐶
𝐹+,𝑉+
) and average von Mises stress for the 
fibrosa and ventricularis RVEs under tension. 
AVIC layer differences under tension: varied connectivity 
With these observations, and knowledge that AVICs may behave phenotypically 
similar throughout the layers, a second parametric study was carried out. The objective 
was to estimate differences in connectivity between the fibrosa and venticularis AVICs.  
A constant AVIC stiffness of 18kPa was used in these studies and the contractility 
parameter measured from the fibrosa AVICs under tension (𝛼𝐴𝑉𝐼𝐶
𝐹+ ) was applied to the 
ventricularis under tension, 𝑅𝑉𝐸𝑉
+. The connectivity parameter, 𝛽𝐴𝑉𝐼𝐶
𝑉+  , was altered until 
the activated tissue stress was matched using the same AVIC stiffness and contractile 
force.  
The approach assumptions are summarized as follows: 
1) The fibrosa AVICs are assumed to be continuously bound to the surrounding 
matrix (𝛽𝐴𝑉𝐼𝐶
𝑙𝑎𝑦𝑒𝑟+
 = 1) 
2) The contractile response of the AVICs under all conditions was assumed to be 
uniform 
3) AVICs in the ventricularis have reduced connectivity to the surrounding matrix 
relative to the fibrosa layer (𝛽𝐴𝑉𝐼𝐶
𝑙𝑎𝑦𝑒𝑟+
<1). 
4) The fibrosa and ventricularis AVICs have negligible connectivity to the 
surrounding matrix when under compression. 
 
Results revealed that AVICs residing in the ventricularis layer appear to have 
approximately 70% less connectivity to the surrounding matrix (𝛽𝐴𝑉𝐼𝐶
𝑙𝑎𝑦𝑒𝑟±
=0.32) relative to 
the fibrosa layer. The model assumes that under compression AVICs behave as if they 
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are essentially disconnected from the ECM entirely as results from macro model revealed 
no contribution from the layers of the AV under compression. Therefore, only the relative 
connectivity between the fibrosa and ventricularis was of interest and reported here 
(Table 3.4).  
AVIC-ECM connectivity differences in the native AV 
Immunofluorescent staining of native porcine AV tissue revealed layer 
differences in F-actin content (Fig. 3.16). Although F-actin content was present in both 
layers, as expected, there appeared to be far higher concentrations in the fibrosa layer 
relative to the ventricularis.  
Pam gel validation 
The macro-micro model detected a shear modulus of approximately 1.8 GPa for 
PMMA particles (Fig. 3.17). Despite this unrealistically high stiffness for biological 
inclusions, the model was still able to capture the shear modulus of the inclusions quite 
accurately. When taken on average, literature reported shear moduli values for PMMA 
using both a torsion pendulum test (1.367GPa) and an anticlastic plate bending test 
(1.575 GPa) [45] were within ± 0.329 GPa of the model’s estimated modulus. 
Validation of the macro-micro model against the Kershaw et al. independent data 
set [42] revealed that to achieve an equivalent contractile response from the normal to the 
hypertensive activation state, the AVICs must exhibit a basal stiffness of 18kPa (𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙) 
and a change in the contractility parameter, 𝛼𝐴𝑉𝐼𝐶
𝑙𝑎𝑦𝑒𝑟±
. The micro-model estimated 
underlying contributions of AVIC contraction to the macro level changes in tissue 
stiffness from the normal to the hyper state to be equivalent to a contractility parameter 
value of 6.98E-5 (1/K). The simulation of the Kershaw study indicated a measured 
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contractility change equivalent to approximately 6E-5 (1/K), indicating good agreement 
with the micro-model estimates.  
DISCUSSION 
AV flexure studies eliciting AVIC contraction observed substantial differences in 
layered behavior [1] as previously noted. The macro-micro model presented above aimed 
to not only capture this bidirectionality of flexure behavior between states, but also shed 
light on possible differences between AVIC contractility in the layers. The model 
suggests that the observed changes at the tissue level are almost entirely due to AVIC 
contraction, with little to no contributions from changes in AVIC intrinsic stiffness 
(3.15). 
By examining the AV under flexural loading more information on layer differences 
was obtained than would have been if examining the layers under simple uniaxial tension. 
Another major finding of this study, although not surprising, is that the fibrosa layer 
appears to be primarily responsible for the observed bidirectional differences in bending 
behavior upon activation. Under tension (AC), the micro-model results revealed 
substantial contributions of AVIC contractility to the tissue-level stiffness changes. The 
ventricularis AVIC contribution was estimated to be approximately 70% less than that of 
the fibrosa AVIC estimated contributions. This finding implies that there are significant 
layer differences between AVIC-ECM connectivity causing these differences in force 
transduction to the surrounding matrix. This observation was reinforced by IHC results 
staining for F-actin networks (indicating attachment to the surrounding matrix) which 
revealed a much more substantial cytoplasmic network of F-actin in the fibrosa layer 
relative to the ventricularis. Additionally, it has been reported that the main mechanism 
by which VICs attach to collagen within the mitral valve leaflet are through α2β1 integrins 
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and these connections are necessary for KCl-induced force generation to occur [46]. 
Given that the fibrosa layer is primarily composed of type 1 collagen, these previous 
observations along with the layer differences reported in this study strongly suggest that 
α2β1 mediated force generation is occurring in the AV as well, contributing to 
substantially different layer contributions to overall observed tissue behavior under 
flexure.  
Results from the estimation of PAM gel inclusions provide a picture of the macro-
micro model sensitivity. Given the ability for the model to detect changes in underlying 
stiffness, it is reasonable to assume that the model is sensitive to changes in stiffness of 
the underlying AVICs. However, this sensitivity is entirely independent of the 
experimental data acquired at the macro scale. The experimental flexural testing 
methodology has previously been validated using silicone rubber sheets, estimating shear 
moduli values within 7% error compared with tensile testing results [39]. The 
independent study performed by Kershaw et al. [42] provided an indication of the 
collective contractile force of the AVICs to achieve a hypertensive state (90mM KCl) 
from a normal baseline (5mM) of approximately 1.41µN per AVIC. This estimate 
provides a realistic number to contrast with the model’s final estimated results for AVIC 
contractility. The reported contractility parameter change of 7E-5 (1/K) between normal 
to hyper states correlates approximately with an AVIC force of 1.60 µN, which is a 
similar value to the Kershaw study estimate of 1.41µN. It is important to note that these 
force correlations are merely estimates based on the assumption that all AVICs are 
contracting in the axial direction and exerting equal forces. They are not meant to be a 




In summary, given the model’s ability to detect small changes in stiffness, we 
have demonstrated that the additional rise in tissue stiffness, measured by the flexure 
studies, was due to an active contraction by the underlying AVICs. Realistically, the 
AVICs stiffness may exhibit a slight increase in intrinsic stiffness, however the model 
indicates this contribution is negligible relative to contractility. Furthermore, observed 
differences in activation response at the tissue level are likely due to vast differences in 
AVIC-ECM connectivity with the surrounding matrix as indicated by the macro-micro 
model estimates of AVIC contractility in the layers. This study further supports the 
pressing need for an in-situ approach given the complexity of the native ECM and the 
intricate variation throughout the layers. Currently, replicating such an environment using 
3D gels (natural or synthetic) is unattainable with current knowledge of the valve 
microstructure. The introduced experimental-computational approach offers a method to 













Table 3.1: List of symbols and nomenclature. 
 
AV Aortic Valve 
ECM Extracellular Matrix 
AC Flexure direction directed against the natural curvature of the leaflet 
WC Flexure direction directed with the natural curvature of the leaflet 
FE Finite Element 
I Second moment of inertia 
Δκ Change in valve leaflet curvature during flexure testing 
M Applied bending moment 
𝑊± Bimodular strain energy function 
𝐸𝑒𝑓𝑓I Flexural stiffness 
F Fibrosa layer 
V Ventricularis layer 
𝑅𝑉𝐸𝑙𝑎𝑦𝑒𝑟± 
Representative Volumetric Element 




Shear modulus of the macro model 
State: inactive, normal, hypertensive 




Volumetric averaged stress of the macro model RVE 
State: inactive, normal, hypertensive 




Volumetric averaged stress of the micro model RVE 
State: inactive, normal, hypertensive 
Layer: Fibrosa (F), Ventricularis (V) Under Tension (+) or Compression (-) 
Φ𝐴𝑉𝐼𝐶  Mass fraction of AVICs 




Baseline shear modulus of ECM 
Layer: Fibrosa (F), Ventricularis (V) Under tension (+) and compression 
𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙












AVIC connectivity to ECM 





































96.19 24.77 ~4:1 
 
Normal 







V 311.93 24.77 ~13:1 
 
Hyper 
F 2250.78 43.76 ~51:1 
0.989 0.28 0.88 
V 311.93 24.77 13:1 
Table 3.2: Estimated moduli values for each layer under tension and compression at 
each activation state: inactive, normal and hypertensive. R
2
 goodness of fit 























Inactive 4.58 3.08 3.46 2.76 
Normal 6.92 3.29 4.90 2.89 
Hyper 8.18 3.29 4.90 2.99 
Table 3.3: Macro homogenized von Mises stress values for each layer under tension 
and compression for each activation state: inactive, normal and 






β𝐴𝑉𝐼𝐶 1 0.32 
Table 3.4: Estimated relative ventricularis connectivity (β𝐴𝑉𝐼𝐶) parameter using the 
estimated uniform AVIC stiffness (𝜇𝐴𝑉𝐼𝐶) of 18kPa and hyper contractility 










Figure 3.2: Macro-micro approach schematic. 
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Figure 3.3: Averaged M vs. Δκ experimental data from AV bending study under 
inactive (thapsigargin), normal (5mM KCl) and hypertensive (90mM KCl) 
conditions and bending with (WC) and against (AC) the natural leaflet 
curvature.   
 
Figure 3.4: Macro-micro model overview depicting the application of boundary 
conditions from the macro nodes to the corresponding micro RVE surface.   
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Figure 3.6: Distribution (a) dimensions (b) and orientation angles (c) of AVICs within 
the micro-model based on histological measurements from native AV tissue 
acquired from [40, 41].   
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Figure 3.7: RVE length vs. stress variation to determine an optimal RVE size of 80µm 
for the micro-model.   
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Figure 3.8: Micro-model framework 
 




Figure 3.10: Figure adapted by [42], illustrating force generation from AV leaflet strips 
using 90mM KCl (a) the FE simulation of the study (b) and the linear 
correlation between the micro-model α parameter and AVIC force. 
 
Figure 3.11: Estimation of the activation parameter necessary to achieve normal and 






Figure 3.12: Linearized effective moduli taken from the slope of the averaged M vs. Δκ 
curve in figure 3.3 at points of maximum common curvature (0.11mm
-1
) 
determined for the inactive, normal and hypertensive states and bending in 
both the AC and WC directions. 
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Figure 3.13: Macro-model simulation results of M- Δκ plotted against the experimental 
AV bending data determined for the inactive, normal and hypertensive states 
and bending in both the AC and WC directions. 
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Figure 3.14: Results of micro-model parametric studies assuming a uniform AVIC-ECM 
connectivity. Effects of AVIC contractility, α, and AVIC stiffness, µ, for the 
fibrosa RVE under tensile loading (a) and the ventricularis RVE under 
tensile loading (b). 
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Figure 3.15: Results of micro-model parametric studies plotted in 3D (new representation 
of figure 3.13 results) assuming a uniform AVIC-ECM connectivity. Effects 
of AVIC contractility, α, and AVIC stiffness, µ, for the fibrosa RVE under 
tensile loading (a) and the ventricularis RVE under tensile loading (b). Flat 
plane indicates the hypertensive stress (Hyper) measured at the tissue level. 
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Figure 3.16: Immunofluorescent imaging of F-actin in native AV histological tissue 
sections. F-actin stained with TRITC conjugated phalloidin and AVIC 
nuclei counterstained with DAPI (blue). Arrows indicate F-actin positive 
staining in AVIC cytoplasm. 
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Figure 3.17: Polyacrylamide gel validation of macro-micro model sensitivity to PMMA 
inclusions. The macro model is fit against the experimental M vs. Δκ 
bending data (top left). The micro-model then estimates a moduli value for 
the inclusion stiffness (top right) and is reported in the table (bottom). 
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CHAPTER 4: MEASURING THE EFFECTS OF CONTRACTILE 
STIMULI ON AVIC BIOMECHANICAL BEHAVIOR IN SITU 
Preface 
Chapters 4 and 5 encompass the final specific aim in this body of work: To 
measure the layer dependent contractile response of AVICs in situ using the developed 
computational-experimental approach in a simulated pathological state. The goal of these 
studies was to measure the in situ layer dependent contractile response of AVICs in a 
simulated pathological state using TGF-β1 and subsequently validate the observed 
contractile response against microindentation experiments (Chapter 5). 
INTRODUCTION 
Transforming growth factor-beta1 (TGF-β1) is a prolific growth factor and has 
been shown to initiate calcification in vitro and accelerate valvular stenosis in vivo [4,5]. 
Immunohistochemical studies revealed the presence of high levels of TGF-β1 in calcified 
human aortic valves when compared to noncalcified [6]. TGF-β1 has also been shown to 
mediate differentiation of VICs into active myofibroblasts in vitro determined by a 
significant increase in α-SMA, a gold standard marker for identifying myofibroblasts,  
augment stress fiber formation and alignment, and increase VIC contractility [7]. The role 
that TGF-β1 plays in calcification of the aortic valve remains unclear, however a number 
of in vitro studies have shown convincing evidence that TGF-β1 induces cell apoptosis, 
cellular aggregation, and calcified nodule formation in VICs.  
To further understand differences in AVIC contractile responses due to varied 
layer connectivity, TGF-β1 was used as a biochemical agent to induce an activated AVIC 
simulating a pathological state [1]. It was hypothesized that observed layer differences in 
AVIC contractile responses would be more pronounced with TGF-β1 treatment due to an 
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enhanced cytoskeletal network, creating even stronger connections to the surrounding 
matrix that would translate to stronger forces. The multi-scale FE model described in 
detail in Chapter 3 was used to evaluate how TGF-β1 affects tissue level bending 
behavior in the AV due to changes in underlying AVIC-ECM coupling and AVIC 
stiffness. An overview of the macro-micro model for end-loading is provided in Fig. 4.1. 
PROTOCOLS 
Tissue preparation and treatment 
All reagents were purchased from ThermoFisher Scientific (Waltham, Ma) unless 
otherwise indicated. Viable porcine AVs were acquired at a local abattoir (Harvest House 
Farms, Johnson City, TX) and kept on ice to ensure AVIC survival during transport. 
Within 1-2 hour of sacrifice, leaflets were dissected from the AVs from the root along 
their attachment points from four animals for a total of 12 AV leaflets. Resected leaflets 
were washed 3 times in cold sterile PBS with 1% Penicillin Streptomycin and transferred 
to Hypothermosol biopreservation media (BioLife Solutions, Bothell, WA). 
Circumferential strips approximately 4mm wide x 14mm long were removed from the 
whole leaflet by cutting just below the nodulus of Arantus with razor blades of a constant 
width (Fig. 4.2). Tissue strips were randomized between the 2 pre-treatment conditions: 
Control and TGF-β1, in a 24 well plate. Each pre-treatment condition had 6 specimens 
(n=6). No distinction was made between the right, left or non-coronary leaflets. Control 
tissue was incubated for a period of five days in low serum culture media consisting of: 
1% fetal bovine serum, 1% L-Glutamine, 1% Penicillin Streptomycin, and 0.5% 
Fungizone Antimycotic in advanced DMEM base media. TGF-β1 samples were 
incubated in the same base media with the addition of 5ng/mL of TGF-β1. Specimens 
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were maintained at 37°C at 5% CO2 for the five day incubation period with fresh media 
exchanges every 48 hours.  
End-loading bending protocol 
 After five days of incubation, tissue strips were removed from culture and 
immediately tested under flexure deformation. Leaflets were bent with (WC) and against 
(AC) the natural leaflet curvature under three activation levels: inactive (cytochalasinD), 
normal (5mM KCl) and hypertensive (90mM KCl).  Each specimen was first tested in 
both directions in 37°C Dulbecco’s Modified Eagle Medium (DMEM), no phenol red 
with high glucose supplemented with 5 mM KCl. Testing media was then changed to 
DMEM with 90mM KCl and the same specimen was allowed to incubate for 10 minutes 
prior to testing a second time in both WC and AC bending directions using the same 
procedure. Last, the same tissue strip was incubated for 10 minutes in 20µM 
Cytochalasin D (CytoD) (Sigma, St. Louis, MO) at 37°C prior to testing again in both the 
WC and AC direction. Several control tissue samples were tested with both 5mM and 
90mM KCl after incubation with CytoD to demonstrate effectiveness of CytoD in 
inhibiting actin polymerization. After no change was observed in stiffness (i.e. no 
contraction) upon addition of 90mM KCl, tissue samples were only tested in 5mM base 
media after CytoD treatment. 
The end-loading flexure testing protocol was introduced in Chapter 2, and 
summarized here with minor modifications. Five small red bead markers were glued on 
the side of the tissue farthest from the free edge for curvature calculation using the macro 
imaging system described in Chapter 2 (Fig. 4.1a). A hollow 19 gauge Teflon needle 
sleeve was glued to one end of the tissue using cyanoacrylate and then slipped onto a 
steel dowel to allow for free rotation and restricted translation of the tissue. The tank-
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tissue holder assembly was mounted to a bi-directional (X1 axis movement) stage fitted 
with two precision linear actuators (model MM-4M-EX80, National Aperture Inc., Salem 
NH). A small amount of cyanoacrylate glue attached a second Teflon needle sleeve to the 
loading end of the tissue; this sleeve then slipped over a vertically mounted 316V 
stainless steel bending bar of known stiffness. The stiffness of the bar determined the 
amount of force produced as a function of the bar’s displacement, eliminating the 
necessity of load cells.  Actuation of the bi-directional stage in the X1-direction moved 
the entire tank and sample, causing the transverse linkage to bend the bending bar. In this 
design, both positive and negative changes in curvature could be tracked, allowing a 
single-run experiment in both the with-curvature (WC) and against-curvature (AC) 
testing directions. For the bending data acquisition, the following information was 
recorded for the duration of the experiment: coordinates of red macro markers, 
displacement of the bending bar, and the current curvature of the tissue.  Analysis of the 
bending data was detailed by [2] and summarized in Chapter 2.  A custom-written 
LabVIEW (National Instruments, Austin,TX) program computed curvature, change in 
curvature, and moment at the middle five markers for each time point of the experiment 
during testing.  The resulting marker positions were fit to a fourth-order polynomial to 
determine the curvature of the tissue.  The initial curvature, 0, was recorded by the 
control system and subtracted from consequent curvature measurements to obtain the 
change in curvature  = -0. Five specimens were tested to a curvature change up to 
0.1-0.20 mm
-1
. The moment was determined by using the position of the central marker 
and the displacement of the bending bar (Eq. 4.1 and Chapter 2, Fig. 2.2a)  
 
M = P y          (4.1) 
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where M is the applied moment, y is the deflection from the horizontal axis, and P is the 
axial force. The displacement of the bending bar was tracked in real-time since the 
applied axial force, P, was a function of the displacement.  The deflection, y (Fig. 2-b) 
was computed using the spatial y coordinate of the central tissue marker and the y 
coordinate of the horizontal axis drawn from post to post. The resulting data is reported 
as the averaged M/I vs. Δκ response of all specimens from each group to normalize with 
respect to specimen geometry (Fig. 4.3a-b). 
Linearized effective modulus 
The effective modulus, Eeff, was determined from a linear regression of the M vs. 
Δκ plots at the maximum Δκ reached for both the control and TGF-β1 groups (Fig. 4.3). 
It is important to clarify that Eeff is simply an estimated index of tissue stiffness as the AV 
bending behavior is not entirely linear. All reported pairwise multiple comparison 
procedures used a one-tailed t-test with an overall significance level of 0.05 performed 
with SigmaPlot (San Jose, CA, USA).  
Tissue bulk modulus estimates using the macro-micro model 
The same moduli relations for inactivated tissue found in [3] and used for fitting 
Merryman et al. data in Chapter 3 were maintained here for the cytochalasin D 
activation state since it was considered to be inactivated through the depolymerization of 
filamentous actin (F-actin). Similarly, the layer differences between relative increase in 
stiffness between the normal and hypertensive states discovered from fitting the same 
data set (Chapter 3) were also maintained. For example, the fibrosa was found to 
increase in tensile stiffness from the inactive to the normal state approximately 4 times 
more than the ventricularis. Therefore, when performing the optimization procedure to fit 
the moduli values from the inactive to the normal state, the fibrosa tensile stiffness was 
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optimized and the ventricularis always proceeded with an increase from inactive of 4 
times less than the fibrosa. Additionally, the compressive moduli values remained the 
same for all three states due to the finding in Chapter 3 that the bidirectional response 
can only be captured when dictated by the layers under tension. Using these assumptions 
based on previous findings, the data from all 4 treatment groups for all activation states 
were fit to the macro model.  
Macro RVE averaged stress 
Extracted nodal and elemental values for displacement and stress from the simulation 
were taken at 0.15mm
-1 
change in curvature. The average stress of the macro RVE 
(Chapter 3, Eq. 3.4 and Eq. 3.11) was computed using a custom Python script, 
extracting the FE estimated stress at all 27 nodes and numerically integrating using a 3-
point Gauss quadrature in three dimensions. 
AVIC stiffness and contractile force estimates using the macro-micro model 
As discussed in detail in Chapter 3, a baseline basal stiffness of AVICs (𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙
) 
was established and validated to be 18kPa. Also, as described previously, AVIC 
contractility state𝛼𝐴𝑉𝐼𝐶
𝑙𝑎𝑦𝑒𝑟+
 was determined from the fibrosa RVE under tension by 
performing a parametric study of the parameter until homogenized macro stress levels 
(state𝜎𝑀𝑎𝑐𝑟𝑜
𝑙𝑎𝑦𝑒𝑟+
) were achieved.  
RESULTS 
Linearized effective modulus of AV leaflets 
There was an observed stiffness increase between the control and TGF-β1 treated 
AVs under flexural deformation (Fig. 4.3). Although direct comparison between the 
activation studies introduced in Chapter 3 and the current study cannot be made due to 
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differences in experimental design, the observed bidirectional response remained aligned 
with previous findings. For example, the linearized modulus estimates (max curvature 
reached common amongst the samples or 0.11mm
-1
) revealed an insignificant increase in 
stiffness from normal to hyper states when bending in the WC direction for both the 
control and the TGF-β1 treated groups (Fig. 4.4). This contrasts with a statistically 
significant increase in stiffness (p=0.01) from the normal to hyper activation states in the 
control group as well as the TGF-β1 treated samples (p=0.007). Comparing control tissue 
against TGF-β1 treated samples, there was no observed statistically significant difference 
in the WC bending direction. However, there was a notable increase in stiffness of the 
TGF-β1 relative to the control for all three activation states (p<0.05) in the AC direction. 
There was a slight fold increase in stiffness change between the normal to 
hypertensive activation observed between the two treatment groups. Control tissue 
increased stiffness approximately 1.48 fold when stimulated with 90mM KCl (hyper) 
from the normal state (5mM). TGF-β1 treated tissue increased stiffness slightly more 
upon 90mM KCl activation with a 1.58-fold increase from normal conditions. 
CytoD treatment was successful in decreasing the F-actin cytoskeletal 
contributions to AVIC stiffness as indicated by the significant decrease in stiffness 
amongst both groups for each bending direction (p<0.05). The inactivated TGF-β1 was 
interestingly found to be significantly stiffer than the control activated group (p=0.011). 
Although reporting the linearized effective modulus Eeff provides a general estimate of 
bending behavior, the true layer behavior must be captured by the estimated shear moduli 
from the macro-model fits to the experimental M vs. Δκ. 
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Tissue bulk modulus estimates using the macro-micro model 
Estimated parameters for each treatment group at each different activation level 
are reported in Table. 4.2. Parameter estimates for the inactivated tissue, although 
substantially lower in magnitude, fit the experimental data well using the same moduli 
relations established for non-viable tissue. To summarize, it was established that an 
approximate 5:1 bimodular relationship exists in the fibrosa layer, contrasted with a 4:1 
relationship found in the ventricularis for inactivated AV tissue. Using these same 
established moduli relationships between tensile and compressive behavior, the goodness 
of fit was more than sufficient with reported R
2
 values of 0.990 and 0.964 for the 
inactivated control and TGF-β1 groups respectively. The TGF-β1 treated tissue was 
found to exhibit an overall higher stiffness (approximately 45%) than the control tissue 
under both tension and compression in both layers for the inactivated state. 
As discussed in the methods, moduli relationships established in Chapter 3 for 
the control tissue were maintained and only the fibrosa modulus was optimized with the 
model. Therefore, the remaining results will be discussed highlighting the fibrosa layer 
responses and comparing the differences between the control and TGF-β1 treated tissue.   
Examining the parameter fits at the normal state (5mM KCl), we observe an 
approximate 2-fold increase in stiffness from the control tissue, contrasted with a similar 
1.8-fold increase from the TGF-β1 group. Although the fold increase from inactive to 
normal is similar amongst the two treatments, the TGF-β1 group had a higher inactivated 
stiffness to start with. This nearly insignificant difference is reflected by the 
tensile/compressive layer moduli ratios reported in Tables 4.3 and 4.4. The fibrosa layer 
of the control tissue was approximately 10 times stiffer under tension than compression, 
contrasted with the TGF-β1 treated tissue showing a fibrosa that was 9 times stiffer under 
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tension. However, it is important to point out that in the normal state, the TGF-β1 treated 
tissue was still found to be approximately 25% stiffer than the control.  
The most substantial difference between the control and TGF-β1 treated tissue is 
the observed stiffness change between the normal and hyper activation states. The control 
tissue increased in fibrosa tensile stiffness approximately 1.48-fold, compared with a 
2.26-fold increase in fibrosa tensile stiffness with TGF-β1 treatment. This is reflected in 
the tensile/compressive layer moduli ratios as a 15:1 ratio in the control tissue, compared 
with a nearly 20:1 ratio for the TGF-β1 treated tissue. 
 Underlying changes in AVIC stiffness and contractile forces 
The estimated contractile force for AVICs in the control specimen at hypertensive 
conditions was approximately 26E-5 1/K (Fig. 4.5a). This value was significantly lower 
than the estimated contractile parameter for AVICs within the TGF-β1 treated tissue of 
approximately 35E-5 (Fig. 4.5b). These results are also plotted in 3D to illustrate 
consistency of the model with findings from Chapter 3, demonstrating insignificant 
contribution of AVIC stiffness to changes in tissue stiffness (Fig. 4.6). It is important to 
also examine what this means in terms of contractile change between normal and hyper 
conditions (Δα in Fig.4.5). For the control tissue, the contractility increased 1.39-fold 
from normal to hyper, contrasted with an increase of 2.05 from the TGF-β1 treated tissue. 
This marks an increase in AVIC contractility of nearly 50% upon activation with TGF-
β1. The connectivity parameter results reveal that relative to the fibrosa layer, the AVICs 
residing in the ventricularis layer are drastically less connected to the surrounding ECM 
(Tables 4.6 and 4.7).  
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DISCUSSION AND CONCLUSIONS 
The TGF-β1 treated tissue was found to exhibit an overall higher stiffness than 
the control tissue. It is possible that over the five day incubation period, the TGF-β1 
treatment could have prompted the AVICs to begin producing ECM at a relatively higher 
rate than the control groups. Additional histological analysis would need to be carried out 
to determine whether or not new collagen had been produced. However, the average 
thickness of the specimens was not higher than that of the control groups indicating that 
whatever new matrix was synthesized is most likely subtle and the flexure test is capable 
of detecting such small changes in stiffness prior to noticeable valve thickening.  
In summary, the study revealed a significant increase in stiffness of the fibrosa 
layer with exogenous TGF-β1 treatment. The layer-dependent increase in stiffness was 
reflected in estimated AVIC contraction, depicting a 1.50-fold increase in AVIC 
contraction relative to the control upon TGF-β1 activation. Whether examining linearized 
estimates of tissue stiffness or the estimated AVIC contraction force, there is a consistent 
45-50% increase in tissue stiffness and underlying AVIC contractility when stimulated 
with TGF-β1 treatment. Furthermore, AVIC connectivity within the ventricularis under 
tension is drastically reduced (>96%) relative to the fibrosa connectivity for both control 
and TGF-β1 treated tissue. This may suggest an increase in ECM degradation in the 
ventricularis caused by matrix metalloproteinases activation due to static incubation for a 
five day period. This would require further investigation such as gene expression of 






AV Aortic Valve 
ECM Extracellular Matrix 
AC Flexure direction directed against the natural curvature of the leaflet 
WC Flexure direction directed with the natural curvature of the leaflet 
FE Finite Element 
I Second moment of inertia 
Δκ Change in valve leaflet curvature during flexure testing 
M Applied bending moment 
𝑊± Bimodular strain energy function 
𝐸𝑒𝑓𝑓I Flexural stiffness 
F Fibrosa layer 
V Ventricularis layer 
𝑅𝑉𝐸𝑙𝑎𝑦𝑒𝑟±  
Representative Volumetric Element 




Shear modulus of the macro model 
State: inactive, normal, hypertensive 




Volumetric averaged stress of the macro model RVE 
State: inactive, normal, hypertensive 




Volumetric averaged stress of the micro model RVE 
State: inactive, normal, hypertensive 
Layer: Fibrosa (F), Ventricularis (V) Under Tension (+) or Compression (-) 
Φ𝐴𝑉𝐼𝐶  Mass fraction of AVICs 




Baseline shear modulus of ECM 
Layer: Fibrosa (F), Ventricularis (V) Under tension (+) and compression 
𝜇𝐴𝑉𝐼𝐶
𝐵𝑎𝑠𝑎𝑙












AVIC connectivity to ECM 




Table 4.1: List of symbols and nomenclature. 
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F 40.0 8.40 ~4.72:1 
0.990 0.36 0.75 
V 18.64 4.80 ~3.88:1 
 
Norm 






V 27.96 4.80 ~5.83:1 
 
Hyper 
F 123.62 8.40 ~14.72:1 
0.984 0.34 0.84 
V 27.96 4.80 ~5.83:1 
Table 4.2: Estimated shear moduli values for the control treatment group at all three 
activation states. Moduli relations were derived from the in depth analysis 
presented in Chapter 3. Schematic detailing neutral axis location trends 































V 27.21 7.0 ~4:1 
 
Norm 







V 40.82 7.0 ~6:1 
 
Hyper 
F 238.73 12.26 ~20:1 
0.972 0.34 0.84 
V 40.82 7.0 ~6:1 
Table 4.3: Estimated shear moduli values for the TGF-β1 treatment group at all three 
activation states. Moduli relations were derived from the in depth analysis 






















Inactive 1.049 0.893 0.965 0.674 
Norm 
2.14 0.893 1.065 0.674 
Hyper 2.66 0.893 1.065 0.674 
Table 4.4: Macro homogenized von Mises stress values for the control tissue for each 
layer under tension and compression for each activation state: inactive, 














Inactive 1.53 1.30 1.41 0.983 
Norm 
2.66 1.30 1.54 0.983 
Hype 4.39 1.30 1.54 0.983 
Table 4.5: Macro homogenized von Mises stress values for the TGF-β1 tissue for each 
layer under tension and compression for each activation state: inactive, 












β𝐴𝑉𝐼𝐶 1 0.034 
Table 4.6: Estimated connectivity (β𝐴𝑉𝐼𝐶) parameters for Control tissue using the 
estimated uniform stiffness of 18kPa (𝜇𝐴𝑉𝐼𝐶), and the uniform estimated 






β𝐴𝑉𝐼𝐶 1 0.035 
Table 4.7: Estimated connectivity (β𝐴𝑉𝐼𝐶) parameters for TGF-β1 treated tissue using 
the estimated uniform stiffness of 18kPa (𝜇𝐴𝑉𝐼𝐶), and the uniform estimated 




Figure 4.1: End-loaded tissue sample (a) and the corresponding macro-model 
simulation (b) which is then mapped down to the micro tissue scale (c) into 
the micro-model (d). For details of the macro-micro model framework the 







Figure 4.2: Aortic valve leaflet illustrating the size and orientation of the 
circumferentially oriented tissue strips extracted from the intact leaflet for 
flexure testing. Schematic adapted from [4]. 
 148 
 
Figure 4.3: Averaged M vs. Δκ experimental data from AV bending study of control 
tissue (a) and TGF-β1 tissue (b) under inactive (CytoD), normal (5mM KCl) 
and hypertensive (90mM) conditions and bending with (WC) and against 
(AC) the natural leaflet curvature. 
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Figure 4.4: Linearized effective moduli from control and TGF-β1  treated tissue taken 
from the slope of the averaged M vs. Δκ curves in Fig. 4.3 at points of 
maximum common curvature (0.11mm
-1
) determined for the inactive, 





Figure 4.5: Results of micro-model parametric studies estimating changes in AVIC 
contractility, Δα, between normal and hyper activation states. Δα is plotted 
for the fibrosa RVE under tensile loading of control tissue (a) and TGF-β1 
treated tissue (b). 
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Figure 4.6: Results of micro-model parametric studies plotted in 3D. Effects of AVIC 
contractility, α, and AVIC stiffness, µ, for the fibrosa RVE under tensile 
loading are plotted for control tissue (a) and TGF-β1 treated tissue (b). Flat 
plane indicates the hypertensive stress (Hyper) measured at the tissue level. 
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CHAPTER 5: MEASURING THE EFFECTS OF CONTRACTILE 
STIMULI ON AVIC MECHANICAL BEHAVIOR USING 
MICROINDENTATION TECHNIQUES 
Preface 
The mechanical properties of VICs have been studied using various experimental 
techniques mentioned previously in Chapter 1, such as micropipette aspiration (MA) [1-
3], collagen-gel contraction [4], and atomic force microscopy (AFM) [4]. These ex-situ 
studies analyzed VICs isolated from the different heart valve leaflet tissues when 
suspended in an aqueous solution (MA), and seeded on a 2D flat substrates (AFM), or 
seeded on collagen gels. Findings from these studies taken with supporting literature [5-
10] suggest that the expression of  -SMA into the stress fibers may enhance the 
contractility and stiffness of these cells. Similarly, upon the disruption of the -SMA rich 
cytoskeleton, the contractile activity is abolished [5, 11, 12]. The case can be made that 
AVIC stiffness measured through AFM allows for a more accurate representation of 
biomechanical properties compared with micropipette aspiration. This is due to the fact 
that during measurements, AVICs are seeded on a collagen substrate, allowing for the 
cytoskeleton to form anchors via focal adhesions on one side of the cell. This is in 
contrast to micropipette aspiration measurements where AVICs are entirely non-adherent, 
making it physically impossible for reaction forces to be generated. However, this ex-situ 
technique remains far from physiologically representative of the AVIC’s native ECM 
connectivity in 3D.  The overall objective of this study is not to derive conclusions on 
AVIC responses to contractile reagents, but instead to compare relative contractile 
responses of AVICs, from a normal or basal tonus state (5mM KCl) to a hypertensive 
state (90mM KCl) with the same relative contractile response measured from the 
developed in situ approach (Chapter 4). We hypothesize that due to additional focal 
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adhesions in the AVIC 3D native environment, the relative increase in contraction and 
associated stiffness will be substantially different than what is measured using 
microindentation techniques. To test this, microindentation studies were carried out in 
collaboration with the Guilak research group at Duke University. 
 
INTRODUCTION 
The effective stiffness of AVICs is a strong indicator of its biosynthetic 
phenotype. In normal healthy valves, AVICs are quiescent with a fibroblast-like 
phenotype [13]. AVIC phenotypic plasticity has been demonstrated through their 
adjustment to dynamic environments through the activation and secretion of proteolytic 
enzymes that mediate extracellular matrix remodeling. Transforming growth factor-beta1 
(TGF-β1) is a prolific growth factor and has been shown to initiate calcification in vitro 
and accelerate valvular stenosis in vivo [4,5]. Immunohistochemical studies have revealed 
the presence of high levels of TGF-β1 in calcified human AVs when compared to 
noncalcified [6]. It has been shown to mediate differentiation of VICs into active 
myofibroblasts in vitro, determined by a significant increase in α-SMA, a gold standard 
marker for identifying myofibroblasts, augmentation of stress fiber formation and 
alignment, and increases in VIC contractility [7]. The role that TGF-β1 plays in 
calcification of the AV remains unclear, however a number of in vitro studies have 
shown convincing evidence that TGF-β1 induces cell apoptosis, cellular aggregation, and 
calcified nodule formation in VICs. To understand differences in AVIC biomechanical 
responses in a simulated disease state and validate the in situ approach in Chapter 4, 
microindentation studies were used to examine AVIC activation with and without TGF- 
β1. The effective modulus of AVICs cultured on a flat thin-layered collagen substrate 
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over glass was measured using AFM technique, modified with a larger spherical indenter 
with 5 μm diameter (i.e. microindentation) to obtain a global response of AVIC 
mechanics. The activation states of the AVICs were then controlled with different 
chemical reagents to alter the biomechanical properties of the stress fibers. Then, using 
the experimental data, we studied both resulting changes in AVIC stiffness and observed 
differences in components of the stress fibers (α-SMA and F-actin). Five experimental 
treatment groups were used: Cytochalasin D pretreated group (CytoD), Control groups 
with 5 mM and 90 mM KCl treatments (C5 and C90 groups, respectively), and 
transforming growth factor-beta1 (TGF-β1) pretreated groups with 5 mM and 90 mM 
KCl treatments (T5 and T90 groups, respectively). For each group, the indentation depth 
vs. force curves were extracted and later fit to a computational model to derive the 
effective modulus (Eeff ) of the AVIC.  
PROTOCOLS 
AVIC culture 
Glass bottom culture dishes (MatTek, Ashland, MA) were coated with collagen 
type 1 (BD Biosciences, San Jose, CA) in 0.02N acetic acid at a concentration of 
10ug/mL. The solubilized collagen solution was incubated on the glass for 1 hour at 
37°C. Excess solution was aspirated and coated dishes were left to dry under UV 
overnight and then rinsed with PBS. Primary porcine VICs were generously provided by 
Dr. Giovanni Ferrari’s research group at the University of Pennsylvania’s Perelman 
School of Medicine. The VICs were isolated from porcine AVs using a modification of 
the method described by Branchetti et al. [14], cryopreserved and shipped on dry ice to 
our laboratory. Primary VICs were thawed and cultured in Dulbecco’s Modified Eagle 
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Medium (DMEM) with high glucose and 10% fetal bovine serum) at 37°C and 5% CO2 
until reaching 80% confluence in monolayer. 
VICs (P2-P4) were lifted from tissue-culture treated flasks and seeded on collagen 
coated coverslips at a concentration of 7,000/cm
2
 and cultured in Dulbecco’s Modified 
Eagle Medium (DMEM) with high glucose and low-serum (LS) medium (1% FBS 
supplemented). VICs were treated for a period of 5 days with additional TGF-β1 
(5ng/mL) (Sigma-Aldrich, St Louis, MO) and control cells were cultured in plain media 
(all conditions were LS). Cultures were replenished with TGF-β1 and fresh media every 
48 hours.  
Pretreatment 
Cytochalasin D (CytoD) is a potent inhibitor of actin polymerization. It binds to 
F-actin and prevents the polymerization of actin monomers. It is thought that the 
mechanism for this action is through binding specifically to the net polymerizing end of 
the filament, preventing the addition of new monomer, while allowing the rate of actin 
monomer loss to continue [2]. As actin monomer loss remains uninhibited, 
depolymerization occurs. Immediate disruption of the ordered cytoskeleton occurs within 
eukaryotes exposed to CytoD, involving breaking of actin filaments. Additionally, a 
secondary response is known to occur where fragmented actin filaments engage in a 
contractile event, causing the formation of filament foci [3]. By disassembling the actin 
network of the VICs, microindentation can be used to measure the baseline global 
stiffness of the AVIC and serve as a negative control throughout the study. The resulting 
stiffness was expected to be similar to that which has been measured using micropipette 
aspiration in previous studies (0.45 kPa) [1]. 
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VICs cultured in standard low serum media, served as a second negative control 
for the TGF-β1 treated VICs. Testing in 5mM KCl mimics a normal physiological 
environment, creating a passive stiffness in the AVIC cytoskeleton. Addition of 90mM 
KCl during microindentation testing initiates active contraction within the VIC 
cytoskeleton and mimics a hypertensive physiological condition. Similarly, testing in 
5mM KCl with the addition of TGF-β1 represents a normal physiological environment, 
enabling the measurement of VIC passive stiffness in a “myofibroblast”-like state. The 
addition of 90mM KCl will allow the measurement of active VIC stiffness under these 
simulated pathological conditions. It is hypothesized that the addition of α-SMA into the 
stress fibers will initiate a more pronounced increase in activated stiffness compared to 
the activated control group (Control 90mM). A summary of the five experimental 
conditions is provided in Table 5.1. 
Microindentation 
After 5 days of incubation, the biomechanical properties of control and TGF-β1 
treated AVICs were measured using an atomic force microscope (MFP-3D, Asylum 
Research, Santa Barbara, CA). The TGF-β1 and non-treated AVICs were first tested 
under normal physiological levels of 5mM KCl at 37°C. The same AVIC sample was 
then incubated at 37°C for 10 minutes in hypertensive levels of KCl (90mM) and 
retested. Finally, the same AVIC sample was treated with 20μM Cytochalasin-D (Sigma-
Aldrich, St Louis, MO) for 10 minutes at 37°C to cause complete depolymerization of the 
actin network and tested using microindentation a third time. To ensure CytoD 
concentration and incubation time was effective, samples were given CytoD 
supplemented with 90mM KCl and measured using microindentation. There was no 
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measured increase in stiffness between the 5mM and 90mM controls when delivered with 
CytoD (data not shown).  
Cantilevers with a borosilicate glass sphere (5μm diameter, Novascan 
Technologies, Ames, IA) were used for all microindentation testing. The cantilever 
spring constant (typically 0.027 N/m) was determined from the spectral density of the 
thermal noise fluctuation prior to testing. Single AVICs were indented (Fig. 5.1a) with an 
approximate step displacement (Z) and the resulting force response was recorded. The 
indentation depth is approximate since it varies with the mechanical properties of each 
AVIC as the experiment is trigger force controlled with a trigger force value of 2.5nN. 
On average, the indentation depth of the TGF-β1 treated AVICs ranged from 0.26-0.30 
microns and the control AVICs experienced a similar 0.3-0.38 indentation depth 
representing approximately 4-6% of the AVIC height. Due to destruction of the 
cytoskeletal network, the CytoD treated AVICs were indented nearly 2 microns prior to 
hitting the 2.5nN trigger force. Three different indentation speeds were used to achieve a 
slow and fast loading cycle to reveal potential strain-rate dependent properties of the 
AVICs (Fig. 5.1b). First, a slow indentation speed was used representing a 300ms 
indentation followed by an immediate 300ms release. Second, a different sampling of 
AVICs from the same sample was indented with a more physiologically relevant speed of 
50ms loading (speed of valve opening and closing), followed by a 50ms release. For each 
of the five experimental conditions (Table 5.1), 60 total AVICs were tested on 3 different 
coverslips using the slow indentation speed and a total of 20 AVICs were tested on 3 
different coverslips using the faster indentation speed. Indentations were performed 
consistently over the nucleus of each AVIC for consistency in measurements (Fig. 5.2). 
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AVIC elastic modulus analysis 
To estimate AVIC effective moduli values, the indentation depth vs. force curves 
were fit to a  thin-layer Hertz equation (Eq. 5.1-5.2) as described in the methods by [15]. 
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where F is the applied force, 𝐸𝑌 is the Young’s modulus, R is the relative radius, for 
spread cells analyzed here, R=Rprobe , where Rprobe is the probe radius, h is the cell height, 
𝜈 is Poisson’s ratio, 𝛿 is the indentation, 𝜒 =
√𝑅𝛿
ℎ
 , and the constants 𝛼𝑜 and  
where F is the applied force, EY is the Young’s modulus, R is the relative radius 
(R=Rprobe), h is the cell height, ν is Poisson’s ratio, δ is the indentation. χ=(√Rδ)/h. α0 and 
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The thin-layer model is appropriate for samples where h≤ 𝑅 [15]. Since all AVIC 
samples tested were far less than 64µm, this model remains appropriate. Additionally, the 
geometry of the sample did not affect the data analysis as applied strains were less than 
10%. For each single AVIC indentation, the initial indentation phase of the acquired 
force-indentation curve, representing the elastic response of the AVIC, was fit to Eq. 5.1 
to determine the elastic modulus, EY.  
Immunofluorescence quantitative analysis  
Immediately following microindentation, AVIC coverslips were washed twice 
with PBS to remove excess media then fixed in 4% Paraformaldehyde (Electron 
Microscopy Sciences, Hatfield, PA) in PBS for 15 minutes. Following fixation, AVICs 
were permeabilized using 0.1% Triton-X-100/PBS and nonspecific binding was blocked 
using 1% BSA for 30 minutes.  AVICs were incubated for 1 hour with α-SMA 
monoclonal antibody (1:125, mouse anti-porcine, ThermoFisher Scientific, Waltham, 
MA). The primary antibody was removed through PBS washes and AVICs were 
incubated with a FITC conjugated secondary antibody (1:125 goat anti-mouse, Millipore, 
Billerica, MA) and TRITC-conjugated Phalloidin (1:100, Millipore) to stain for 
filamentous actin (F-actin). AVICs were stained with DAPI (Life Technologies, 
Carlsbad, CA) for 5 minutes prior to mounting with ProLong Diamond Antifade 
mountant (ThermoFisher Scientific).  
Fluorescent images were taken from each of the 5 experimental groups (CytoD, 
Control 5mM, Control 90mM, TGF-β1 5mM and TGF-β1 90mM). A minimum of 10 
images was taken from each group (20x objective, TRITC, FITC, DAPI filters) with a 
fluorescent microscope (Zeiss Axiovert 200M, Zeiss, Germany). Exposure time remained 
constant to allow for a relative quantitative analysis between groups. A custom Python 
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script was then used to quantify relative amounts of free α-SMA protein, F-actin and α-
SMA positive F-actin (colocalization of α-SMA into the F-actin cytoskeleton). 
 
RESULTS 
Observed differences in measured AVIC biomechanical state 
In all cases, the CytoD treatment (negative control) significantly reduced the 
modulus of the AVICs more than 10-fold compared to the control (C5), indicating its 
effectiveness in abolishing the AVIC cytoskeleton (p<0.001, one-way ANOVA). The 
resulting stiffness of 0.52 kPa was found to be similar to that which has been measured 
using micropipette aspiration in previous studies (0.45 kPa) [1].  
Normal activation conditions (5mM KCl) revealed no differences in stiffness 
between the control vs. TGF-β1 treated AVICs (Fig. 5.3). Additionally, there were no 
observed difference resulting from different indentation speeds at this particular 
activation level.  
Both control and TGF-β1 AVICs experienced a significant increase in stiffness 
with the addition of 90mM KCl (p<0.04, using two-tailed t-test comparisons of each 
treatment group). Interestingly, when examining differences between control and TGF-β1 
treated AVICs at the normal activation state using the slow indentation speed, differences 
were insignificant. However, when the speed of indentation increased (5 times the speed), 
there was a significant change in estimated moduli values for the TGF-β1, establishing a 
statistical difference between the control AVICs (p=0.007) Fig. 5.4. For clarity, the 
estimated moduli values are also reported comparing groups within a single indentation 
speed in Fig. 5.5a (slow) and Fig. 5.5b (Fast). 
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Examining the fold change upon activation with 90mM KCl, the differences are 
quite pronounced when compared to the slower indentation rate. Control AVICs 
exhibited an approximate 1.54-fold increase, contrasted with a 1.45-fold increase from 
TGF-β1 treated AVICs when evaluated with a slower indentation speed. Interestingly, 
higher rates of indentation increased this difference in fold change tremendously. 
Measured changes in control stiffness from 5 to 90mM KCl jumped from 1.54 to 1.75, 
with an even more drastic change in the TGF-β1 from 1.45 to 2.09. 
Immunofluorescent staining of samples immediately after microindentation 
testing revealed interesting changes in relative F-actin and α-SMA protein content 
between groups (Fig. 5.6-5.7). Under 5mM activation conditions, there were no observed 
differences in α-SMA content between groups, however, as expected CytoD treatment 
eliminated nearly all of the F-actin cytoskeleton. These results are quantitatively reported 
in Figs. 5.8). Upon activation with 90mM KCl, both control and TGF-β1 AVICs 
experienced an upregulation of F-actin formation as well as an increase in α-SMA 
content (Fig. 5.8-5.9). The most marked change in α-SMA protein content was observed 
in the TGF-β1 treated AVICs. Furthermore, when examining the composite image 
(yellow Fig. 5.7) it is clear that the α-SMA has been incorporated in the F-actin network 
through both qualitative observation and quantitative measurements (Fig. 5.10). This is in 
contrast to control AVICs at 90mM, which did exhibit an upregulation in α-SMA protein, 
although modest (30% less than TGF-β1 AVICs). 
DISCUSSION 
Significant differences in fold change from underlying AVIC contraction upon 
TGF-β1 may be alluded to α--sma recruitment into the f-actin stress fibers as observed 
from immunofluorescent imaging. Referencing ongoing related work in our group by 
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Yusuke Sakamoto, the presented microindentation data is being used to develop an 
improved computational model of a VIC by incorporating a more realistic stress fiber 
model. Then, by integrating the experimental data of the AVICs into the model, how the 
stress fibers in the AVICs adapt to different activation states can be observed. Even more 
importantly the model is capable of capturing how different components of the stress 
fibers, F-actin and α-SMA, affect the stress fiber biomechanics (Fig. 5.11). 
The most interesting and unexpected finding from this study was the strain rate 
sensitivity observed in the AVIC response to activation stimuli. Higher rates of 
indentation revealed significant differences between the TGF-β1 treated AVICs in the 
90mM hypertensive condition and control AVICs. These differences were not evident 
using a slower strain rate (5-fold reduction in speed) and may suggest a rate dependence 
of the cytoskeletal structure, particularly α-SMA positive stress fibers. This may be 
linked to physiological responses of AVICs. AVICs reside in a high speed, dynamic 
environment in vivo, suggesting that larger cyclic strain magnitude on tissue may activate 
the AVICs. This suggests that a time-dependent model may be needed that captures 
inertial effects, viscoelasticity and poroelasticity of the AVICs in future modeling efforts. 
When comparing the results from the microindentation study with the observed 
fold increase from in situ measurements (Chapter 4) relative trends comparing control 
vs. TGF-β1 contractile behavior appear consistent. The estimated contractility increase 
measured with the in situ approach for control tissue was found to be approximately 1.4, 
compared with a 2.0-fold increase observed in TGF-β1 treated tissue. If we contrast this 
with the observed fold change from physiologically relevant strain rates: 1.75 for control 
and 2.0 for TGF-β1. Although the trends remain the same between microindentation and 
in situ estimates of AVIC contractility, it seems that the relative effects of TGF-β1 
treatment were more pronounced when measured in situ. To summarize, the in situ 
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estimates revealed a 45-50% increase in contractile response upon TGF-β1 
activation, contrasted with a mere 14% increase difference from microindentation 
measurements. 
 











Table 5.1: Summary of treatment groups and abbreviated names. Two pre-treatments 
(control and TGF-β1 tested under 3 different activation states: inactive, 
normal (5mM) and hypertensive (90mM). CytoD treatment served as a 
negative control for an inactivated cytoskeletal network. 
 
 
Figure 5.1: Schematic of microindentation on an AVIC with a 5 micron glass bead (a) 
and the two different indentation protocols used in the current study. 
 165 
 
Figure 5.2: Single AVIC cells during indentation using a 5μm AFM cantilever tip (0.03 
N/m).   
 
Figure 5.3: Effective modulus measurements from microindentation of AVICs under 
CytoD, Control and TGF-β1 treatments in response to normal activation 




Figure 5.4: Effective modulus measurements from microindentation of AVICs under 
CytoD, Control and TGF-β1 treatments in response to hyper activation 





Figure 5.5: Effective modulus measurements from microindentation of AVICs under 
CytoD, Control and TGF-β1 treatments in response to hyper activation 
conditions (90mM). The same results from Fig. 5.3 and 5.4 are plotted side 
by side to illustrate the strain-rate dependency of the TGF-β1 effect on 







Figure 5.6: Fluorescent staining of AVICs on collagen substrates immediately following 
microindentation experiments in 5mM KCl conditions. Images were taken 
using a constant exposure time to evaluate F-actin (orange), α-SMA (green), 
nuclei (blue) and α-SMA positive stress fibers seen in composite images 




Figure 5.7: Fluorescent staining of AVICs on collagen substrates immediately following 
microindentation experiments in 90mM KCl conditions. Images were taken 
using a constant exposure time to evaluate F-actin (orange), α-SMA (green), 
nuclei (blue) and α-SMA positive stress fibers seen in composite images 
(yellow). All images taken with a 63x objective. 
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Figure 5.8: Relative fluorescent quantification of filamentous actin (orange fluorescent 
in Figs 5.6 and 5.7) between all 5 treatment groups. Fluorescence was 
normalized to TGF-β1 fluorescence at 90mM, as this group exhibited the 
greatest intensity of staining. 
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Figure 5.9: Relative fluorescent quantification of α-SMA protein (green fluorescent in 
Figs 5.6 and 5.7) between all 5 treatment groups. Fluorescence was 
normalized to TGF-β1 fluorescence at 90mM, as this group exhibited the 
greatest intensity of staining. 
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Figure 5.10: Relative fluorescent quantification of α-SMA protein colocalized into F-
actin fibers (yellow fluorescent in Figs 5.6 and 5.7) between all 5 treatment 
groups. Fluorescence was normalized to TGF-β1 fluorescence at 90mM, as 










Figure 5.11: A schematic of a computational model of the AVICs that incorporates 
different mechanical constituent of the stress fibers (Top). Resulting 
contributions of F-actin and α-SMA to the maximum stress fiber contractile 
strength measured from the developed model. [This work was submitted to 
the Summer Biomechanics Bioengineering and Biotransport Conference for 
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CHAPTER 6: SUMMARY, CONCLUSIONS AND FUTURE 
DIRECTIONS 
SUMMARY 
The overall goal of this work was to estimate AVIC biomechanical state from 
tissue-level measurements to gain physiologically relevant information regarding AVIC 
layer dependent behavior under different activation states. The ability to predict the 
biomechanical state of the AVIC from biomechanical tissue experiments provides a 
significant advantage in that they remain in their native environment. The developed 
novel computational-experimental approach is a means of deconvoluting changes in 
AVIC stiffness and AVIC-ECM coupling. This information will provide insight into 
disease and treatment mechanisms of calcific aortic valve disease giving rise to early 
detection and better treatment options.  
As a first step, a tissue-level bilayer model that accurately captures the 
bidirectional flexural response of AV intact layers in a passive state was developed. 
Through this study, the behavior of AV leaflet tissue as a composite beam was 
determined by examining the M-Δk relationship and the transmural strain of the tissue 
during bending. It was concluded that while it has been previously speculated that valve 
layers slide with respect to one another during valve opening/closing, our evidence 
suggests that the leaflet layers function as a single bonded unit. Furthermore, the valve 
tissue in flexure requires a bimodular material model to capture the layer dependent 
responses imposed from underlying AVIC activation. 
Next, tissue micromorphology was incorporated in a macro-micro scale 
framework to simulate layer-specific AVIC-ECM interactions. The macro-micro AV 
model built using an integrated computational-experimental approach, demonstrated the 
ability to probe layer differences in AVIC-ECM connectivity. Findings suggest that 
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observed layer differences under flexural deformation at the tissue level during AVIC 
contraction are due to differences in AVIC connectivity with the surrounding matrix. 
Specifically, it was estimated that AVIC connectivity to the surrounding matrix was 
approximately 70% less than AVIC connectivity in the fibrosa layer.  
 The developed macro-micro model was then used to assess differences in AVIC 
activation states in situ by simulating AVIC pathological state through exogenous TGF-
β1 treatment. The study revealed a significant increase in stiffness of the fibrosa layer 
with exogenous TGF-β1 treatment. The layered-dependent increase in stiffness was 
reflected in estimated AVIC contraction, depicting a 1.50-fold increase in AVIC 
contraction relative to the control upon TGF-β1 activation. Whether examining linearized 
estimates of tissue stiffness or the estimated AVIC contraction force, there was a 
consistent 45-50% increase in tissue stiffness and underlying AVIC contractility when 
stimulated with TGF-β1 treatment.  
Last, we have shown that using an in situ approach to estimate the biomechanical 
state of AVICs under varying activation stimuli tells a different story than using ex situ 
measurements alone. Microindentation studies examining AVIC activation were run in 
parallel with in-situ studies to emphasize the necessity of an in-situ approach, and the 
advantage it affords over existing ex-situ methodology. When comparing the results from 
the microindentation study with the in situ measurements, relative trends comparing 
control vs. TGF-β1 contractile behavior appear consistent. The estimated contractility 
increase measured with the in situ approach for control tissue was found to be 
approximately 1.4, compared with a 2.0-fold increase observed in TGF-β1 treated tissue. 
If we contrast this with the observed fold change from micro indentation measurements 
using physiologically relevant strain rates: 1.75 for control and 2.0 for TGF-β1, the trends 
remain the same between microindentation and in situ estimates of AVIC contractility, 
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however the relative effects of TGF-β1 treatment were more pronounced when measured 
in situ. Specifically, the in situ estimates revealed a 45-50% increase in contractile 
response upon TGF-β1 activation compared to controls, contrasted with a mere 14% 
increase difference from microindentation measurements. 
CONCLUSIONS 
In conclusion, the developed numerical-experimental methodology can be used to obtain 
AVIC properties in-situ, uncovering AVIC-ECM coupling behavior present in native 
tissue that is otherwise unattainable using existing experimental techniques or 
computational approaches alone. This work represents the first evidence that AVICs 
couple in a layer specific manner during contraction, contributing to observed layer 
differences at the tissue level under flexural loading patterns. Information gained using 
this developed analytical tool will provide insight into disease and treatment mechanisms 
of calcific aortic valve disease giving rise to early detection and better treatment options. 
FUTURE DIRECTIONS 
The developed macro-micro framework should be considered a first step to 
understanding the complex interactions between the AVICs and surrounding ECM. This 
simplified model focuses on one component of the complete cardiac cycle: opening and 
closing of leaflets under systolic stress levels. Future experimental studies of the AV will 
be done in the loaded state (diastole) under equibiaxial tension. These future experiments 
will aid in developing a model of the AVIC-ECM interactions under the complete cardiac 
cycle.  
Currently our group is working on subcellular models that incorporate the 
intricacy of the cytoskeletal network. Particularly the differences observed in the 
discussed microindentation experiments between the α-sma positive fibers. Initial 
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findings have observed that the incorporation of α-SMA is what contributes to the 
measured increase in contractile force of the AVICs. The next step would be to 
incorporate this improved AVIC model into the micro framework of the macro-micro 
model. As we gain further insight into the AV microenvironment, we can continue to add 
to the complexity of the macro-micro model while maintaining the computational-
experimental approach. 
As mentioned previously, although 3D gel studies are not physically realistic, 
they can provide valuable insight due to their tunability. For example, to further validate 
these findings of contractile differences due to varied coupling, an artificial type 1 
collagen gel system could be engineered to replicate native density differences of 
integrins. This simple approach would enable the evaluation of AVICs with known 
connectivity to the matrix under contractile stimuli. These experiments could be used in 
conjunction with the developed macro-micro model to estimate AVIC contractile 
responses in this artificial environment.  
As mentioned throughout this work, calcification is the primary cause of AV 
failure and currently no approved medical means of halting progression exists. However, 
a pharmaceutical class of 3-hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) 
reductase inhibitors commonly referred to as statins has shown potential in slowing 
calcification. Statins are used clinically to mitigate mortality rates in atherosclerotic 
patients by lowering LDL serum cholesterol. Additionally, statins have been shown to 
inhibit calcified nodule formation in AVIC in vitro cultures via contraction regulation [1, 
2]. Despite the knowledge gained from these in vitro studies, the in situ effects of statins 
on AVICs remain largely unknown. In vitro findings have demonstrated a high ECM 
dependence of statin influence on AVIC behavior, highlighting the importance of in situ 
investigation [3, 4]. Thus, deriving the biomechanical state of AVICs in situ using the 
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developed computational-experimental modeling approach could reveal more accurate 
information regarding AVIC responses to statins and other potential pharmaceutical 
interventions for mitigating AVIC pathological progression. 
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